Explore
Validate
Learn
Western blot
Flow cytometryAntibody data
- Antibody Data
- Antigen structure
- References [272]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
- Immunohistochemistry [1]
- Chromatin Immunoprecipitation [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MA1-39540 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- Estrogen Receptor alpha Monoclonal Antibody (SP1)
- Antibody type
- Monoclonal
- Antigen
- Synthetic peptide
- Description
- This antibody is predicted to react with porcine based on sequence homology. Heat-mediated antigen retrieval is recommended prior to staining, using a 10mM citrate buffer, pH 6.0, for 10 minutes followed by cooling at room temperature for 20 min. Following antigen retrieval, incubate samples with primary antibody for 30 min at room temperature. A suggested positive control is breast carcinoma.
- Reactivity
- Human
- Host
- Rabbit
- Isotype
- IgG
- Antibody clone number
- SP1
- Vial size
- 1 mL
- Concentration
- 0.015 mg/mL
- Storage
- -20° C, Avoid Freeze/Thaw Cycles
Submitted references Levels of sex steroid hormones and their receptors in women with preeclampsia.
Profiling protein expression in circulating tumour cells using microfluidic western blotting.
Integrated Molecular Characterization of Uterine Carcinosarcoma.
The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ERα.
Context Specificity in Causal Signaling Networks Revealed by Phosphoprotein Profiling.
High-Risk Premenopausal Luminal A Breast Cancer Patients Derive no Benefit from Adjuvant Cyclophosphamide-based Chemotherapy: Results from the DBCG77B Clinical Trial.
Effects of CDK4/6 Inhibition in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Cells with Acquired Resistance to Paclitaxel.
Tumour and cellular distribution of activated forms of PR in breast cancers: a novel immunohistochemical analysis of a large clinical cohort.
Polymorphisms of glutathione S-transferase π 1 and toll-like receptors 2 and 9: Association with breast cancer susceptibility.
Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of Ki67 assay according to histology: prognostic relevance for resected early stage 'pure' and 'mixed' lobular breast cancer.
Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models.
Asymptomatic Benign Papilloma Without Atypia Diagnosed at Ultrasonography-Guided 14-Gauge Core Needle Biopsy: Which Subgroup can be Managed by Observation?
Runx2 Expression as a Potential Prognostic Marker in Invasive Ductal Breast Carcinoma.
Abiraterone acetate, exemestane or the combination in postmenopausal patients with estrogen receptor-positive metastatic breast cancer.
Changes in miR-221/222 Levels in Invasive and In Situ Carcinomas of the Breast: Differences in Association with Estrogen Receptor and TIMP3 Expression Levels.
Increased CD4 and CD8-positive T cell infiltrate signifies good prognosis in a subset of triple-negative breast cancer.
Impact of immunohistochemistry-based molecular subtype on chemosensitivity and survival in Hispanic breast cancer patients following neoadjuvant chemotherapy.
Expression of Lipid Metabolism-Related Proteins in Metastatic Breast Cancer.
Differential expression of lipid metabolism-related proteins in different breast cancer subtypes.
Upregulation of IGF-1R expression during neoadjuvant therapy predicts poor outcome in breast cancer patients.
The clinicopathological and prognostic significance of CD24, CD44, CD133, ALDH1 expressions in invasive ductal carcinoma of the breast: CD44/CD24 expression in breast cancer.
Hexokinase and phosphofructokinase activity and intracellular distribution correlate with aggressiveness and invasiveness of human breast carcinoma.
Propagation of oestrogen receptor-positive and oestrogen-responsive normal human breast cells in culture.
MYC is expressed in the stromal and epithelial cells of primary breast carcinoma and paired nodal metastases.
Estrogen receptor α regulates non-canonical autophagy that provides stress resistance to neuroblastoma and breast cancer cells and involves BAG3 function.
Midostaurin preferentially attenuates proliferation of triple-negative breast cancer cell lines through inhibition of Aurora kinase family.
Loss of ERβ expression in papillary thyroid carcinoma is associated with recurrence in young female.
Transcriptomic Profiling of Sequential Tumors from Breast Cancer Patients Provides a Global View of Metastatic Expression Changes Following Endocrine Therapy.
Role of epithelial-mesenchymal transition markers in triple-negative breast cancer.
Epstein-Barr virus-associated lymphoepithelioma-like cholangiocarcinoma: a rare variant of intrahepatic cholangiocarcinoma with favourable outcome.
17β-estradiol regulates giant vesicle formation via estrogen receptor-alpha in human breast cancer cells.
Comparison of estrogen receptor-α, progesterone receptor and calponin expression in gonadotrophin-releasing hormone agonist-sensitive and -resistant uterine fibroids.
T47D breast cancer cells switch from ER/HER to HER/c-Src signaling upon acquiring resistance to the antiestrogen fulvestrant.
Differentiation and histogenesis of syringomatous tumour of the nipple and low-grade adenosquamous carcinoma: evidence for a common origin.
Ovarian-cell-like cells from skin stem cells restored estradiol production and estrus cycling in ovariectomized mice.
A current perspective on the pathological assessment of FOXL2 in adult-type granulosa cell tumours of the ovary.
A tissue quality index: an intrinsic control for measurement of effects of preanalytical variables on FFPE tissue.
Assessment of microtubule-associated protein (MAP)-Tau expression as a predictive and prognostic marker in TACT; a trial assessing substitution of sequential docetaxel for FEC as adjuvant chemotherapy for early breast cancer.
Patient-derived xenografts of triple-negative breast cancer reproduce molecular features of patient tumors and respond to mTOR inhibition.
Lack of correlation of stem cell markers in breast cancer stem cells.
Prognostic significance of deregulated dicer expression in breast cancer.
Hormone receptors and age distribution in breast cancer patients at a university hospital in northern egypt.
An associated classification of triple negative breast cancer: the risk of relapse and the response to chemotherapy.
AGR2 predicts tamoxifen resistance in postmenopausal breast cancer patients.
A real-time spectral mapper as an emerging diagnostic technology in biomedical sciences.
HER2/neu gene determination in women screened for breast carcinoma: how screening programs reduce the skyrocketing cost of targeted therapy.
The identification of a small but significant subset of patients still targetable with anti-HER2 inhibitors when affected by triple negative breast carcinoma.
Cyclooxygenase-2 169C>G and 8473T>C gene polymorphisms and prostaglandin E2 level in breast cancer: a case-control study.
Estrogen receptor alpha/beta ratio and estrogen receptor beta as predictors of endocrine therapy responsiveness-a randomized neoadjuvant trial comparison between anastrozole and tamoxifen for the treatment of postmenopausal breast cancer.
Florid lobular carcinoma in situ: molecular profiling and comparison to classic lobular carcinoma in situ and pleomorphic lobular carcinoma in situ.
The prognostic significance of metaplastic carcinoma of the breast (MCB)--a case controlled comparison study with infiltrating ductal carcinoma.
Prediction of Oncotype DX and TAILORx risk categories using histopathological and immunohistochemical markers by classification and regression tree (CART) analysis.
The prevalence of immunohistochemically determined oestrogen receptor positivity in primary breast cancer is dependent on the choice of antibody and method of heat-induced epitope retrieval - prognostic implications?
Predicting response to the anti-estrogen fulvestrant in recurrent ovarian cancer.
Basal cytokeratin as a potential marker of low risk of invasion in ductal carcinoma in situ.
Estrogen receptor α is the major driving factor for growth in tamoxifen-resistant breast cancer and supported by HER/ERK signaling.
Expression of steroid receptor coactivator 3 in ovarian epithelial cancer is a poor prognostic factor and a marker for platinum resistance.
Extranuclear ERα is associated with regression of T47D PKCα-overexpressing, tamoxifen-resistant breast cancer.
Risk predictors of underestimation and the need for sentinel node biopsy in patients diagnosed with ductal carcinoma in situ by preoperative needle biopsy.
Oestrogen increases the activity of oestrogen receptor negative breast cancer stem cells through paracrine EGFR and Notch signalling.
The prognostic role of preoperative and (early) postoperatively change in CA15.3 serum levels in a single hospital cohort of primary operable breast cancers.
Associations between the Expression of Mucins (MUC1, MUC2, MUC5AC, and MUC6) and Clinicopathologic Parameters of Human Breast Ductal Carcinomas.
Synchronous ductal carcinoma in situ of the breast and within epithelial inclusions in an ipsilateral sentinel lymph node.
Comparison of the PharmDx immunohistochemical system with standard methods for assessing estrogen and progesterone receptors in invasive carcinoma of the breast.
Can additional immunohistochemistry staining replace the surgical excision for the diagnosis of papillary breast lesions classified as benign on 14-gage core needle biopsy?
TIMP1 overexpression mediates resistance of MCF-7 human breast cancer cells to fulvestrant and down-regulates progesterone receptor expression.
Prognostic comparison of the proliferation markers (mitotic activity index, phosphohistone H3, Ki67), steroid receptors, HER2, high molecular weight cytokeratins and classical prognostic factors in T₁₋₂N₀M₀ breast cancer.
Prognostic comparison of the proliferation markers (mitotic activity index, phosphohistone H3, Ki67), steroid receptors, HER2, high molecular weight cytokeratins and classical prognostic factors in T₁₋₂N₀M₀ breast cancer.
Genomic and phenotypic profiles of two Brazilian breast cancer cell lines derived from primary human tumors.
Identification of estrogen receptor dimer selective ligands reveals growth-inhibitory effects on cells that co-express ERα and ERβ.
Proteomic analyses reveal high expression of decorin and endoplasmin (HSP90B1) are associated with breast cancer metastasis and decreased survival.
Leiomyomatosis peritonealis disseminata associated with endometriosis and multiple uterus-like mass: report of two cases.
Arginase activity in patients with breast cancer: an analysis of plasma, tumors, and its relationship with the presence of the estrogen receptor.
Molecular alterations between the primary breast cancer and the subsequent locoregional/metastatic tumor.
Accessory breast cancer occurring concurrently with bilateral primary invasive breast carcinomas: a report of two cases and literature review.
Inverse expression of cystein-rich 61 (Cyr61/CCN1) and connective tissue growth factor (CTGF/CCN2) in borderline tumors and carcinomas of the ovary.
The prognostic value of MARCKS-like 1 in lymph node-negative breast cancer.
Akt expression and compartmentalization in prediction of clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab.
Applying the 2011 St Gallen panel of prognostic markers on a large single hospital cohort of consecutively treated primary operable breast cancers.
Correlation between HER2 gene amplification and protein overexpression through fluorescence in situ hybridization and immunohistochemistry in breast carcinoma patients.
Histological analysis of benign breast imaging reporting and data system categories 4c and 5 breast lesions in imaging study.
A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin and trastuzumab for T2 breast cancers.
The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: a histologically high-grade and clinically aggressive tumor.
Increased FDG uptake in breast cancer is associated with prognostic factors.
TRADD contributes to tumour suppression by regulating ULF-dependent p19Arf ubiquitylation.
Estrogen receptor alpha mediates progestin-induced mammary tumor growth by interacting with progesterone receptors at the cyclin D1/MYC promoters.
A 10-year follow-up of triple-negative breast cancer patients in Taiwan.
Concurrent endometrial intraepithelial carcinoma (EIC) and serous ovarian cancer: can EIC be seen as the precursor lesion?
MiR-34b is associated with clinical outcome in triple-negative breast cancer patients.
Clinicopathologic features of the mixed epithelial and mesenchymal type metaplastic breast carcinoma with myoepithelial differentiation in a subset of six cases.
Vaginal superficial myofibroblastoma: a rare mesenchymal tumor of the lower female genital tract and a study of its association with viral infection.
The hormone receptor, human epidermal growth factor receptor 2, and molecular subtype status of individual tumor foci in multifocal/multicentric invasive ductal carcinoma of breast.
Reconstruction of nuclear receptor network reveals that NR2E3 is a novel upstream regulator of ESR1 in breast cancer.
Routine pathologic parameters can predict Oncotype DX recurrence scores in subsets of ER positive patients: who does not always need testing?
A new case of primary signet-ring cell carcinoma of the cervix with prominent endometrial and myometrial involvement: Immunohistochemical and molecular studies and review of the literature.
Cytoplasmic estrogen receptor in breast cancer.
Characteristics and outcomes according to molecular subtypes of breast cancer as classified by a panel of four biomarkers using immunohistochemistry.
Breast cancers presenting luminal B subtype features show higher discordant human epidermal growth factor receptor 2 results between immunohistochemistry and fluorescence in situ hybridization.
Heterogeneity of ERα and ErbB2 Status in Cell Lines and Circulating Tumor Cells of Metastatic Breast Cancer Patients.
Heterogeneity of ERα and ErbB2 Status in Cell Lines and Circulating Tumor Cells of Metastatic Breast Cancer Patients.
Homeodomain-interacting protein kinase 1 (HIPK1) expression in breast cancer tissues.
Quantitative assessment of effect of preanalytic cold ischemic time on protein expression in breast cancer tissues.
FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma.
Cytologic features of triple-negative breast carcinoma.
The pathologic characteristics of breast cancer in China and its shift during 1999-2008: a national-wide multicenter cross-sectional image over 10 years.
Prediction of the shrinking rate of uterine leiomyoma nodules using needle biopsy specimens.
Neovascularization evaluated by CD105 correlates well with prognostic factors in breast cancers.
Invasive lobular carcinoma with extracellular mucin as a distinct variant of lobular carcinoma: a case report.
mTOR in breast cancer: differential expression in triple-negative and non-triple-negative tumors.
Stromal caveolin-1 expression in breast carcinoma. Correlation with early tumor recurrence and clinical outcome.
KX-01, a novel Src kinase inhibitor directed toward the peptide substrate site, synergizes with tamoxifen in estrogen receptor α positive breast cancer.
Implementation of TMA and digitalization in routine diagnostics of breast pathology.
Clinical significance of KISS1 protein expression for brain invasion and metastasis.
Clinical and pathological features of breast cancer associated with the pathological complete response to anthracycline-based neoadjuvant chemotherapy.
Tumor topoisomerase II alpha status and response to anthracycline-based neoadjuvant chemotherapy in breast cancer.
Evaluation of prognostic factors in stage IIA breast tumors and their correlation with mortality risk.
Evaluation of prognostic factors in stage IIA breast tumors and their correlation with mortality risk.
Analysis of peptidyl-propyl-cis/trans isomerase 1 (PIN1) gene -842(G > C) and -667(T > C) polymorphic variants in relation to breast cancer risk and clinico-pathological parameters.
Molecular phenotypes of matched in situ and invasive components of breast carcinomas.
Investigation of galectin-3 and heparanase in endometrioid and serous carcinomas of the endometrium and correlation with known predictors of survival.
Androgen receptor expression in primary breast cancer and its predictive and prognostic value in patients treated with neoadjuvant chemotherapy.
May metaplastic breast carcinomas be actually basal-like carcinoma? Further evidence study with its ultrastructure and survival analysis.
Quantitative determination of estrogen receptor, progesterone receptor, and HER2 mRNA in formalin-fixed paraffin-embedded tissue--a new option for predictive biomarker assessment in breast cancer.
The feasibility of endoscopy-assisted breast conservation surgery for patients with early breast cancer.
Sclerosing polycystic adenosis of the parotid gland: report of a bifocal, paucicystic variant with ductal carcinoma in situ and pronounced stromal distortion mimicking invasive carcinoma.
Unusual finding of endocervical-like mucinous epithelium in continuity with urothelium in endocervicosis of the urinary bladder.
Cytokeratin 5 positive cells represent a steroid receptor negative and therapy resistant subpopulation in luminal breast cancers.
Amplification of the prolactin receptor gene in mammary lobular neoplasia.
Promoter CpG island hypermethylation during breast cancer progression.
Prognostic significance of triple negative breast cancer at tumor size 1 cm and smaller.
Estrogen receptor expression in sporadic vestibular schwannomas.
A case of prostatic adenocarcinoma with aberrant p63 expression: presentation with detailed immunohistochemical study and FISH analysis.
Estrogen-independent actions of environmentally relevant AhR-agonists in human endometrial epithelial cells.
Dietary patterns and risk of breast cancer.
Effects of long-term storage on the detection of proteins, DNA, and mRNA in tissue microarray slides.
Correlation of histologic grade with other clinicopathological parameters, intrinsic subtype, and patients' clinical outcome in Taiwanese women.
Recurrence of benign meningiomas: predictive value of proliferative index, BCL2, p53, hormonal receptors and HER2 expression.
Dendritic cells treated with HPV16mE7 in a three-dimensional model promote the secretion of IL-12p70 and IFN-γ.
Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers.
Serial changes in the expression of breast cancer-related proteins in response to neoadjuvant chemotherapy.
D2-40/p63 defined lymph vessel invasion has additional prognostic value in highly proliferating operable node negative breast cancer patients.
Factors affecting estrogen receptor status in a multiracial Asian country: an analysis of 3557 cases.
Mutations in the epidermal growth factor receptor (EGFR) gene in triple negative breast cancer: possible implications for targeted therapy.
Molecular subtypes and tumor response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.
Primary adenocarcinoma of the rectovaginal septum arising in pregnancy in the absence of endometriosis.
Low-grade salivary duct carcinoma of the parotid gland: report of a case with immunohistochemical analysis.
Clinicopathologic features of 2 new cases of uterine tumors resembling ovarian sex cord tumors.
Prolactin and oestrogen synergistically regulate gene expression and proliferation of breast cancer cells.
The reliability of rabbit monoclonal antibodies in the immunohistochemical assessment of estrogen receptors, progesterone receptors, and HER2 in human breast carcinomas.
Human epidermal growth factor receptor 2 assessment in a case-control study: comparison of fluorescence in situ hybridization and quantitative reverse transcription polymerase chain reaction performed by central laboratories.
Adenoid cystic carcinomas of the breast have low Topo IIα expression but frequently overexpress EGFR protein without EGFR gene amplification.
The quantitative detection of total HER2 load by quantum dots and the identification of a new subtype of breast cancer with different 5-year prognosis.
Effect of neoadjuvant anthracycline-taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study.
Tissue-specific pathways for estrogen regulation of ovarian cancer growth and metastasis.
Prospective multicenter comparison of proliferation and other prognostic factors in lymph node negative lobular invasive breast cancer.
Molecular characterization of breast cancer in young Brazilian women.
Molecular characterization of breast cancer in young Brazilian women.
Immunohistochemical expression of estrogen and progesterone receptors in endometrial polyps and its relationship to clinical parameters.
Expression of androgen receptors in primary breast cancer.
Immunohistochemical expression of estrogen receptor in adenocarcinomas of the lung: the antibody factor.
p16INK4a expression in basal-like breast carcinoma.
The new platinum(IV) derivative LA-12 shows stronger inhibitory effect on Hsp90 function compared to cisplatin.
High-grade endometrial carcinoma: serous and grade 3 endometrioid carcinomas have different immunophenotypes and outcomes.
Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor-positive human breast cancer.
Citraconic anhydride: a new antigen retrieval solution.
A class discovery and class prediction approach to histopathological classification of mammographic screen detected columnar cell lesions of the breast.
Triple-negative breast cancer: clinicopathological characteristics and relationship with basal-like breast cancer.
Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients.
Prognostic significance of Dicer expression in ovarian cancer-link to global microRNA changes and oestrogen receptor expression.
A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers.
Clinicopathological and immunohistochemical analysis of sclerosing stromal tumours of the ovary.
Biologic profiling of lymph node negative breast cancers by means of microRNA expression.
Clinicopathological significance of calreticulin in breast invasive ductal carcinoma.
Papillary apocrine metaplasia and columnar cell lesion with atypia: is there a shared common pathway?
An illegitimate microRNA target site within the 3' UTR of MDM4 affects ovarian cancer progression and chemosensitivity.
The pro-metastatic protein anterior gradient-2 predicts poor prognosis in tamoxifen-treated breast cancers.
Human mammary fibroblasts stimulate invasion of breast cancer cells in a three-dimensional culture and increase stroma development in mouse xenografts.
Assessment of the tumorigenesis and drug susceptibility of three new canine mammary tumor cell lines.
Protein and gene expression of estrogen receptor alpha and nuclear morphology of two breast cancer cell lines after different fixation methods.
COX-2 expression does not correlate with microvessel density in breast cancer.
Evaluation of estrogen treatment in an immunodeficient mouse endometriosis model.
Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients.
RET finger protein expression in invasive breast carcinoma: relationship between RFP and ErbB2 expression.
Declining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community setting.
Identification of biology-based breast cancer types with distinct predictive and prognostic features: role of steroid hormone and HER2 receptor expression in patients treated with neoadjuvant anthracycline/taxane-based chemotherapy.
Gene expression profiling of the tumor microenvironment during breast cancer progression.
Immunohistochemical analysis of ER, PR, Her2 and CK5/6 in infiltrative breast carcinomas in Indian patients.
There are no estrogen and progesterone receptors in cerebral cavernomas: a preliminary immunohistochemical study.
Expression of KAI1/CD82 in distant metastases from estrogen receptor-negative breast cancer.
Reduced prediagnostic 25-hydroxyvitamin D levels in women with breast cancer: a nested case-control study.
Vessel density assessed by endoglin expression in breast carcinomas with different expression profiles.
Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs).
Cytological criteria to predict basal phenotype of breast carcinomas.
Synchronous presentation of uterine leiomyosarcoma and retroperitoneal liposarcoma: analysis by comparative genomic hybridization and review of the literature.
Short-term outcome of primary operated early breast cancer by hormone and HER-2 receptors.
Ductal lavage is an inefficient method of biomarker measurement in high-risk women.
Normal breast tissue implanted into athymic nude mice identifies biomarkers of the effects of human pregnancy levels of estrogen.
Rabbit antibodies for hormone receptors and HER2 evaluation in breast cancer.
Rabbit antibodies for hormone receptors and HER2 evaluation in breast cancer.
Uterine carcinosarcoma metastatic to the lung as large-cell neuroendocrine carcinoma with synchronous sarcoid granulomatosis.
Expression of ER, Ki-67 and cylinD1 in the pre-cancerous breast of Chinese patients.
Triple negative breast carcinoma is a prognostic factor in Taiwanese women.
Tissue microarray validation: a methodologic study with special reference to lung cancer.
The potential biomarkers in predicting pathologic response of breast cancer to three different chemotherapy regimens: a case control study.
A limited panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary.
Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive.
Apolipoprotein D predicts adverse outcome in women >or=70 years with operable breast cancer.
Evaluation of new monoclonal antibodies in detection of estrogen receptor, progesterone receptor, and Her2 protein expression in breast carcinoma cell block sections using conventional microscopy and quantitative image analysis.
Correlation of ultrasound findings with histology, tumor grade, and biological markers in breast cancer.
Rabbit monoclonal antibodies show higher sensitivity than mouse monoclonals for estrogen and progesterone receptor evaluation in breast cancer by immunohistochemistry.
Apocrine carcinomas of the breast in Turkish women: hormone receptors, c-erbB-2 and p53 immunoexpression.
The coexistence of invasive ductal carcinoma and malignant phyllodes tumor with liposarcomatous and chondrosarcomatous differentiation in the same breast in a post-osteosarcoma case.
ERalpha-status of disseminated tumour cells in bone marrow of primary breast cancer patients.
Can clinically relevant prognostic subsets of breast cancer patients with four or more involved axillary lymph nodes be identified through immunohistochemical biomarkers? A tissue microarray feasibility study.
Expression of basal keratins and vimentin in breast cancers of young women correlates with adverse pathologic parameters.
In vivo measurement of tumor estradiol and vascular endothelial growth factor in breast cancer patients.
Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype.
Down-regulation of claudin-2 in breast carcinomas is associated with advanced disease.
Distribution and significance of caveolin 2 expression in normal breast and invasive breast cancer: an immunofluorescence and immunohistochemical analysis.
Age interacts with the expression of steroid and HER-2 receptors in operable invasive breast cancer.
Parafibromin expression in breast cancer: a novel marker for prognostication?
Prostanoid receptor EP1 expression in breast cancer.
Stromal mast cells in invasive breast cancer are a marker of favourable prognosis: a study of 4,444 cases.
Clinical validation of a customized multiple signature microarray for breast cancer.
Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist?
Both germ line and somatic genetics of the p53 pathway affect ovarian cancer incidence and survival.
Expression of aromatase and estrogen receptors in human adrenocortical tumors.
Amplified in breast cancer 1 expression in breast cancer.
Amplified in breast cancer 1 expression in breast cancer.
Prognostic relevance of androgen receptor detection in operable breast cancer.
Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 cases.
In early-stage breast cancer, the estrogen receptor interacts with correlation between human epidermal growth factor receptor 2 status and age at diagnosis, tumor grade, and lymph node involvement.
An oestrogen-dependent model of breast cancer created by transformation of normal human mammary epithelial cells.
Expression of c-kit proto-oncogene product in breast cancer tissues.
Expression of c-kit proto-oncogene product in breast cancer tissues.
Matrix metalloproteinase expression patterns in luminal A type breast carcinomas.
Matrix metalloproteinase expression patterns in luminal A type breast carcinomas.
Primary neuroendocrine carcinoma of the breast: a case report.
Primary neuroendocrine carcinoma of the breast: a case report.
Estrogen insensitivity in a model of estrogen receptor positive breast cancer lymph node metastasis.
Testosterone increases blood flow and expression of androgen and estrogen receptors in the rat vagina.
P27 V109G Polymorphism is associated with lymph node metastases but not with increased risk of breast cancer.
Grading invasive ductal carcinoma of the breast: advantages of using automated proliferation index instead of mitotic count.
Transitional cell carcinoma of the endometrium associated with benign ovarian brenner tumor: a case report with immunohistochemistry molecular analysis and a review of the literature.
The contribution of bifunctional SkipDewax pretreatment solution, rabbit monoclonal antibodies, and polymer detection systems in immunohistochemistry.
Characterization of a preclinical model of simultaneous breast and ovarian cancer progression.
Prognostic factors in Hungarian breast cancer patients.
Anaplastic thyroid carcinoma: expression profile of targets for therapy offers new insights for disease treatment.
Mammary fibroadenoma in a lamb.
Mammary fibroadenoma in a lamb.
A novel dual-target steroid sulfatase inhibitor and antiestrogen: SR 16157, a promising agent for the therapy of breast cancer.
FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
Villoglandular adenocarcinoma of the cervix: two new cases with morphological and molecular study.
The significance of c-erbB-2 overexpression and p53 expression in patients with axillary lymph node--negative breast cancer: a tissue microarray study.
Para-testicular cellular angiofibroma: a rare tumour in a male renal transplant patient.
Ovarian metastases of intestinal-type gastric carcinoma: A clinicopathologic study of 4 cases with contrasting features to those of the Krukenberg tumor.
Hypercalcemia induced by ovarian clear cell carcinoma producing all transcriptional variants of parathyroid hormone-related peptide gene during pregnancy.
Effect of c-neu/ ErbB2 expression levels on estrogen receptor alpha-dependent proliferation in mammary epithelial cells: implications for breast cancer biology.
Antagonist-induced, activation function-2-independent estrogen receptor alpha phosphorylation.
Conditionally activated E7 proteins of high-risk and low-risk human papillomaviruses induce S phase in postmitotic, differentiated human keratinocytes.
Preoperative and intraoperative diagnosis of low-grade adenosquamous carcinoma of the breast: potential diagnostic pitfalls.
Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survival.
Estradiol increases VEGF in human breast studied by whole-tissue culture.
Insulin-like growth factor binding protein 2 is a marker for antiestrogen resistant human breast cancer cell lines but is not a major growth regulator.
Synchronous endometrial and cervical tumors in a 26-year-old nullipara: diagnostic modalities updated.
p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas.
Mucinous cystic tumor of the pancreas with ovarian-like mesenchymal stroma in a male patient.
Endocrine biomarkers in ductal lavage samples from women at high risk for breast cancer.
Primary squamous cell carcinoma of the endometrium: a case report with immunohistochemical and molecular study.
The activation function-1 domain of estrogen receptor alpha in uterine stromal cells is required for mouse but not human uterine epithelial response to estrogen.
Endogenous aromatization of testosterone results in growth stimulation of the human MCF-7 breast cancer cell line.
A membrane estrogen receptor mediates intracellular calcium release in astrocytes.
Lan KC, Lai YJ, Cheng HH, Tsai NC, Su YT, Tsai CC, Hsu TY
Reproductive biology and endocrinology : RB&E 2020 Feb 18;18(1):12
Reproductive biology and endocrinology : RB&E 2020 Feb 18;18(1):12
Profiling protein expression in circulating tumour cells using microfluidic western blotting.
Sinkala E, Sollier-Christen E, Renier C, Rosàs-Canyelles E, Che J, Heirich K, Duncombe TA, Vlassakis J, Yamauchi KA, Huang H, Jeffrey SS, Herr AE
Nature communications 2017 Mar 23;8:14622
Nature communications 2017 Mar 23;8:14622
Integrated Molecular Characterization of Uterine Carcinosarcoma.
Cherniack AD, Shen H, Walter V, Stewart C, Murray BA, Bowlby R, Hu X, Ling S, Soslow RA, Broaddus RR, Zuna RE, Robertson G, Laird PW, Kucherlapati R, Mills GB, Cancer Genome Atlas Research Network, Weinstein JN, Zhang J, Akbani R, Levine DA
Cancer cell 2017 Mar 13;31(3):411-423
Cancer cell 2017 Mar 13;31(3):411-423
The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ERα.
Britschgi A, Duss S, Kim S, Couto JP, Brinkhaus H, Koren S, De Silva D, Mertz KD, Kaup D, Varga Z, Voshol H, Vissieres A, Leroy C, Roloff T, Stadler MB, Scheel CH, Miraglia LJ, Orth AP, Bonamy GM, Reddy VA, Bentires-Alj M
Nature 2017 Jan 26;541(7638):541-545
Nature 2017 Jan 26;541(7638):541-545
Context Specificity in Causal Signaling Networks Revealed by Phosphoprotein Profiling.
Hill SM, Nesser NK, Johnson-Camacho K, Jeffress M, Johnson A, Boniface C, Spencer SE, Lu Y, Heiser LM, Lawrence Y, Pande NT, Korkola JE, Gray JW, Mills GB, Mukherjee S, Spellman PT
Cell systems 2017 Jan 25;4(1):73-83.e10
Cell systems 2017 Jan 25;4(1):73-83.e10
High-Risk Premenopausal Luminal A Breast Cancer Patients Derive no Benefit from Adjuvant Cyclophosphamide-based Chemotherapy: Results from the DBCG77B Clinical Trial.
Nielsen TO, Jensen MB, Burugu S, Gao D, Jørgensen CL, Balslev E, Ejlertsen B
Clinical cancer research : an official journal of the American Association for Cancer Research 2017 Feb 15;23(4):946-953
Clinical cancer research : an official journal of the American Association for Cancer Research 2017 Feb 15;23(4):946-953
Effects of CDK4/6 Inhibition in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Cells with Acquired Resistance to Paclitaxel.
Trapé AP, Liu S, Cortes AC, Ueno NT, Gonzalez-Angulo AM
Journal of Cancer 2016;7(8):947-56
Journal of Cancer 2016;7(8):947-56
Tumour and cellular distribution of activated forms of PR in breast cancers: a novel immunohistochemical analysis of a large clinical cohort.
Bonneterre J, Bosq J, Jamme P, Valent A, Gilles EM, Zukiwski AA, Fuqua SA, Lange CA, O'Shaughnessy J
ESMO open 2016;1(4):e000072
ESMO open 2016;1(4):e000072
Polymorphisms of glutathione S-transferase π 1 and toll-like receptors 2 and 9: Association with breast cancer susceptibility.
Al-Harras MF, Houssen ME, Shaker ME, Farag K, Farouk O, Monir R, El-Mahdy R, Abo-Hashem EM
Oncology letters 2016 Mar;11(3):2182-2188
Oncology letters 2016 Mar;11(3):2182-2188
Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of Ki67 assay according to histology: prognostic relevance for resected early stage 'pure' and 'mixed' lobular breast cancer.
Carbognin L, Sperduti I, Brunelli M, Marcolini L, Nortilli R, Pilotto S, Zampiva I, Merler S, Fiorio E, Filippi E, Manfrin E, Pellini F, Bonetti F, Pollini GP, Tortora G, Bria E
Journal of experimental & clinical cancer research : CR 2016 Mar 22;35:50
Journal of experimental & clinical cancer research : CR 2016 Mar 22;35:50
Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models.
Koussounadis A, Langdon SP, Um I, Kay C, Francis KE, Harrison DJ, Smith VA
BMC cancer 2016 Mar 10;16:205
BMC cancer 2016 Mar 10;16:205
Asymptomatic Benign Papilloma Without Atypia Diagnosed at Ultrasonography-Guided 14-Gauge Core Needle Biopsy: Which Subgroup can be Managed by Observation?
Kim SY, Kim EK, Lee HS, Kim MJ, Yoon JH, Koo JS, Moon HJ
Annals of surgical oncology 2016 Jun;23(6):1860-6
Annals of surgical oncology 2016 Jun;23(6):1860-6
Runx2 Expression as a Potential Prognostic Marker in Invasive Ductal Breast Carcinoma.
El-Gendi SM, Mostafa MF
Pathology oncology research : POR 2016 Jul;22(3):461-70
Pathology oncology research : POR 2016 Jul;22(3):461-70
Abiraterone acetate, exemestane or the combination in postmenopausal patients with estrogen receptor-positive metastatic breast cancer.
O'Shaughnessy J, Campone M, Brain E, Neven P, Hayes D, Bondarenko I, Griffin TW, Martin J, De Porre P, Kheoh T, Yu MK, Peng W, Johnston S
Annals of oncology : official journal of the European Society for Medical Oncology 2016 Jan;27(1):106-13
Annals of oncology : official journal of the European Society for Medical Oncology 2016 Jan;27(1):106-13
Changes in miR-221/222 Levels in Invasive and In Situ Carcinomas of the Breast: Differences in Association with Estrogen Receptor and TIMP3 Expression Levels.
Petrovic N, Davidovic R, Jovanovic-Cupic S, Krajnovic M, Lukic S, Petrovic M, Roganovic J
Molecular diagnosis & therapy 2016 Dec;20(6):603-615
Molecular diagnosis & therapy 2016 Dec;20(6):603-615
Increased CD4 and CD8-positive T cell infiltrate signifies good prognosis in a subset of triple-negative breast cancer.
Matsumoto H, Thike AA, Li H, Yeong J, Koo SL, Dent RA, Tan PH, Iqbal J
Breast cancer research and treatment 2016 Apr;156(2):237-47
Breast cancer research and treatment 2016 Apr;156(2):237-47
Impact of immunohistochemistry-based molecular subtype on chemosensitivity and survival in Hispanic breast cancer patients following neoadjuvant chemotherapy.
Gómez R, Ossa CA, Montoya ME, Echeverri C, Ángel G, Ascuntar J, Borrero M, Gil M, Herrera S, Gutiérrez E, Herazo F, Jiménez A, Madrid J, Reyes PA, Zuluaga L, García H
Ecancermedicalscience 2015;9:562
Ecancermedicalscience 2015;9:562
Expression of Lipid Metabolism-Related Proteins in Metastatic Breast Cancer.
Jung YY, Kim HM, Koo JS
PloS one 2015;10(9):e0137204
PloS one 2015;10(9):e0137204
Differential expression of lipid metabolism-related proteins in different breast cancer subtypes.
Kim S, Lee Y, Koo JS
PloS one 2015;10(3):e0119473
PloS one 2015;10(3):e0119473
Upregulation of IGF-1R expression during neoadjuvant therapy predicts poor outcome in breast cancer patients.
Heskamp S, Boerman OC, Molkenboer-Kuenen JD, Wauters CA, Strobbe LJ, Mandigers CM, Bult P, Oyen WJ, van der Graaf WT, van Laarhoven HW
PloS one 2015;10(2):e0117745
PloS one 2015;10(2):e0117745
The clinicopathological and prognostic significance of CD24, CD44, CD133, ALDH1 expressions in invasive ductal carcinoma of the breast: CD44/CD24 expression in breast cancer.
Kapucuoğlu N, Bozkurt KK, Başpınar Ş, Koçer M, Eroğlu HE, Akdeniz R, Akçil M
Pathology, research and practice 2015 Oct;211(10):740-7
Pathology, research and practice 2015 Oct;211(10):740-7
Hexokinase and phosphofructokinase activity and intracellular distribution correlate with aggressiveness and invasiveness of human breast carcinoma.
Coelho RG, Calaça IC, Celestrini DM, Correia-Carneiro AH, Costa MM, Zancan P, Sola-Penna M
Oncotarget 2015 Oct 6;6(30):29375-87
Oncotarget 2015 Oct 6;6(30):29375-87
Propagation of oestrogen receptor-positive and oestrogen-responsive normal human breast cells in culture.
Fridriksdottir AJ, Kim J, Villadsen R, Klitgaard MC, Hopkinson BM, Petersen OW, Rønnov-Jessen L
Nature communications 2015 Nov 13;6:8786
Nature communications 2015 Nov 13;6:8786
MYC is expressed in the stromal and epithelial cells of primary breast carcinoma and paired nodal metastases.
Mundim FG, Pasini FS, Brentani MM, Soares FA, Nonogaki S, Waitzberg AF
Molecular and clinical oncology 2015 May;3(3):506-514
Molecular and clinical oncology 2015 May;3(3):506-514
Estrogen receptor α regulates non-canonical autophagy that provides stress resistance to neuroblastoma and breast cancer cells and involves BAG3 function.
Felzen V, Hiebel C, Koziollek-Drechsler I, Reißig S, Wolfrum U, Kögel D, Brandts C, Behl C, Morawe T
Cell death & disease 2015 Jul 9;6(7):e1812
Cell death & disease 2015 Jul 9;6(7):e1812
Midostaurin preferentially attenuates proliferation of triple-negative breast cancer cell lines through inhibition of Aurora kinase family.
Kawai M, Nakashima A, Kamada S, Kikkawa U
Journal of biomedical science 2015 Jul 4;22(1):48
Journal of biomedical science 2015 Jul 4;22(1):48
Loss of ERβ expression in papillary thyroid carcinoma is associated with recurrence in young female.
Ahn HY, Kim MS, Kim MJ, Cho SY, Kim YA, Lee GH, Lee BC, Park YJ, Yi KH
Clinical endocrinology 2015 Feb;82(2):300-6
Clinical endocrinology 2015 Feb;82(2):300-6
Transcriptomic Profiling of Sequential Tumors from Breast Cancer Patients Provides a Global View of Metastatic Expression Changes Following Endocrine Therapy.
McBryan J, Fagan A, McCartan D, Bane FT, Varešlija D, Cocchiglia S, Byrne C, Bolger J, McIlroy M, Hudson L, Tibbitts P, Gaora PÓ, Hill AD, Young LS
Clinical cancer research : an official journal of the American Association for Cancer Research 2015 Dec 1;21(23):5371-9
Clinical cancer research : an official journal of the American Association for Cancer Research 2015 Dec 1;21(23):5371-9
Role of epithelial-mesenchymal transition markers in triple-negative breast cancer.
Cheung SY, Boey YJ, Koh VC, Thike AA, Lim JC, Iqbal J, Tan PH
Breast cancer research and treatment 2015 Aug;152(3):489-98
Breast cancer research and treatment 2015 Aug;152(3):489-98
Epstein-Barr virus-associated lymphoepithelioma-like cholangiocarcinoma: a rare variant of intrahepatic cholangiocarcinoma with favourable outcome.
Chan AW, Tong JH, Sung MY, Lai PB, To KF
Histopathology 2014 Nov;65(5):674-83
Histopathology 2014 Nov;65(5):674-83
17β-estradiol regulates giant vesicle formation via estrogen receptor-alpha in human breast cancer cells.
Wright PK, Jones SB, Ardern N, Ward R, Clarke RB, Sotgia F, Lisanti MP, Landberg G, Lamb R
Oncotarget 2014 May 30;5(10):3055-65
Oncotarget 2014 May 30;5(10):3055-65
Comparison of estrogen receptor-α, progesterone receptor and calponin expression in gonadotrophin-releasing hormone agonist-sensitive and -resistant uterine fibroids.
Kim EH, Kim JY, Lee YH, Chong GO, Park JY, Hong DG
Obstetrics & gynecology science 2014 Mar;57(2):144-50
Obstetrics & gynecology science 2014 Mar;57(2):144-50
T47D breast cancer cells switch from ER/HER to HER/c-Src signaling upon acquiring resistance to the antiestrogen fulvestrant.
Kirkegaard T, Hansen SK, Larsen SL, Reiter BE, Sørensen BS, Lykkesfeldt AE
Cancer letters 2014 Mar 1;344(1):90-100
Cancer letters 2014 Mar 1;344(1):90-100
Differentiation and histogenesis of syringomatous tumour of the nipple and low-grade adenosquamous carcinoma: evidence for a common origin.
Boecker W, Stenman G, Loening T, Andersson MK, Sinn HP, Barth P, Oberhellmann F, Bos I, Berg T, Marusic Z, Samoilova V, Buchwalow I
Histopathology 2014 Jul;65(1):9-23
Histopathology 2014 Jul;65(1):9-23
Ovarian-cell-like cells from skin stem cells restored estradiol production and estrus cycling in ovariectomized mice.
Park BW, Pan B, Toms D, Huynh E, Byun JH, Lee YM, Shen W, Rho GJ, Li J
Stem cells and development 2014 Jul 15;23(14):1647-58
Stem cells and development 2014 Jul 15;23(14):1647-58
A current perspective on the pathological assessment of FOXL2 in adult-type granulosa cell tumours of the ovary.
Kommoss S, Gilks CB, Penzel R, Herpel E, Mackenzie R, Huntsman D, Schirmacher P, Anglesio M, Schmidt D, Kommoss F
Histopathology 2014 Feb;64(3):380-8
Histopathology 2014 Feb;64(3):380-8
A tissue quality index: an intrinsic control for measurement of effects of preanalytical variables on FFPE tissue.
Neumeister VM, Parisi F, England AM, Siddiqui S, Anagnostou V, Zarrella E, Vassilakopolou M, Bai Y, Saylor S, Sapino A, Kluger Y, Hicks DG, Bussolati G, Kwei S, Rimm DL
Laboratory investigation; a journal of technical methods and pathology 2014 Apr;94(4):467-74
Laboratory investigation; a journal of technical methods and pathology 2014 Apr;94(4):467-74
Assessment of microtubule-associated protein (MAP)-Tau expression as a predictive and prognostic marker in TACT; a trial assessing substitution of sequential docetaxel for FEC as adjuvant chemotherapy for early breast cancer.
Irshad S, Gillett C, Pinder SE, A'hern RP, Dowsett M, Ellis IO, Bartlett JM, Bliss JM, Hanby A, Johnston S, Barrett-Lee P, Ellis P, Tutt A
Breast cancer research and treatment 2014 Apr;144(2):331-41
Breast cancer research and treatment 2014 Apr;144(2):331-41
Patient-derived xenografts of triple-negative breast cancer reproduce molecular features of patient tumors and respond to mTOR inhibition.
Zhang H, Cohen AL, Krishnakumar S, Wapnir IL, Veeriah S, Deng G, Coram MA, Piskun CM, Longacre TA, Herrler M, Frimannsson DO, Telli ML, Dirbas FM, Matin AC, Dairkee SH, Larijani B, Glinsky GV, Bild AH, Jeffrey SS
Breast cancer research : BCR 2014 Apr 7;16(2):R36
Breast cancer research : BCR 2014 Apr 7;16(2):R36
Lack of correlation of stem cell markers in breast cancer stem cells.
Liu Y, Nenutil R, Appleyard MV, Murray K, Boylan M, Thompson AM, Coates PJ
British journal of cancer 2014 Apr 15;110(8):2063-71
British journal of cancer 2014 Apr 15;110(8):2063-71
Prognostic significance of deregulated dicer expression in breast cancer.
Caffrey E, Ingoldsby H, Wall D, Webber M, Dinneen K, Murillo LS, Inderhaug C, Newell J, Gupta S, Callagy G
PloS one 2013;8(12):e83724
PloS one 2013;8(12):e83724
Hormone receptors and age distribution in breast cancer patients at a university hospital in northern egypt.
Hussein O, Mosbah M, Farouk O, Farag K, El-Saed A, Arafa M, Abdallah A
Breast cancer : basic and clinical research 2013;7:51-7
Breast cancer : basic and clinical research 2013;7:51-7
An associated classification of triple negative breast cancer: the risk of relapse and the response to chemotherapy.
Zhang J, Wang Y, Yin Q, Zhang W, Zhang T, Niu Y
International journal of clinical and experimental pathology 2013;6(7):1380-91
International journal of clinical and experimental pathology 2013;6(7):1380-91
AGR2 predicts tamoxifen resistance in postmenopausal breast cancer patients.
Hrstka R, Brychtova V, Fabian P, Vojtesek B, Svoboda M
Disease markers 2013;35(4):207-12
Disease markers 2013;35(4):207-12
A real-time spectral mapper as an emerging diagnostic technology in biomedical sciences.
Epitropou G, Kavvadias V, Iliou D, Stathopoulos E, Balas C
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2013;2013:1422-5
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2013;2013:1422-5
HER2/neu gene determination in women screened for breast carcinoma: how screening programs reduce the skyrocketing cost of targeted therapy.
Brunelli M, Manfrin E, Bria E, Massari F, Tortora G, Brunello E, Carbognin L, Nottegar A, Furlanetto J, Molino A, Fiorio E, Chilosi M, Jasani B, Vergine M, Marcolini L, Filippini D, Scarpa A, Martignoni G, Bonetti F, Members of Veneto Region - Pathology Screening Group
Anticancer research 2013 Sep;33(9):3705-10
Anticancer research 2013 Sep;33(9):3705-10
The identification of a small but significant subset of patients still targetable with anti-HER2 inhibitors when affected by triple negative breast carcinoma.
Brunello E, Bogina G, Bria E, Vergine M, Zamboni G, Pedron S, Daniele I, Furlanetto J, Carbognin L, Marconi M, Manfrin E, Ibrahim M, Miller K, Tortora G, Molino A, Jasani B, Beccari S, Bonetti F, Chilosi M, Martignoni G, Brunelli M
Journal of cancer research and clinical oncology 2013 Sep;139(9):1563-8
Journal of cancer research and clinical oncology 2013 Sep;139(9):1563-8
Cyclooxygenase-2 169C>G and 8473T>C gene polymorphisms and prostaglandin E2 level in breast cancer: a case-control study.
Fawzy MS, Aly NM, Shalaby SM, El-Sawy WH, Abdul-Maksoud RS
Gene 2013 Sep 25;527(2):601-5
Gene 2013 Sep 25;527(2):601-5
Estrogen receptor alpha/beta ratio and estrogen receptor beta as predictors of endocrine therapy responsiveness-a randomized neoadjuvant trial comparison between anastrozole and tamoxifen for the treatment of postmenopausal breast cancer.
Madeira M, Mattar A, Logullo AF, Soares FA, Gebrim LH
BMC cancer 2013 Sep 18;13:425
BMC cancer 2013 Sep 18;13:425
Florid lobular carcinoma in situ: molecular profiling and comparison to classic lobular carcinoma in situ and pleomorphic lobular carcinoma in situ.
Shin SJ, Lal A, De Vries S, Suzuki J, Roy R, Hwang ES, Schnitt SJ, Waldman FM, Chen YY
Human pathology 2013 Oct;44(10):1998-2009
Human pathology 2013 Oct;44(10):1998-2009
The prognostic significance of metaplastic carcinoma of the breast (MCB)--a case controlled comparison study with infiltrating ductal carcinoma.
Lai HW, Tseng LM, Chang TW, Kuo YL, Hsieh CM, Chen ST, Kuo SJ, Su CC, Chen DR
Breast (Edinburgh, Scotland) 2013 Oct;22(5):968-73
Breast (Edinburgh, Scotland) 2013 Oct;22(5):968-73
Prediction of Oncotype DX and TAILORx risk categories using histopathological and immunohistochemical markers by classification and regression tree (CART) analysis.
Ingoldsby H, Webber M, Wall D, Scarrott C, Newell J, Callagy G
Breast (Edinburgh, Scotland) 2013 Oct;22(5):879-86
Breast (Edinburgh, Scotland) 2013 Oct;22(5):879-86
The prevalence of immunohistochemically determined oestrogen receptor positivity in primary breast cancer is dependent on the choice of antibody and method of heat-induced epitope retrieval - prognostic implications?
Grabau DA, Bendahl PO, Rydén L, Stål O, Fernö M, South and South-East Swedish Breast Cancer Groups
Acta oncologica (Stockholm, Sweden) 2013 Nov;52(8):1657-66
Acta oncologica (Stockholm, Sweden) 2013 Nov;52(8):1657-66
Predicting response to the anti-estrogen fulvestrant in recurrent ovarian cancer.
Argenta PA, Um I, Kay C, Harrison D, Faratian D, Sueblinvong T, Geller MA, Langdon SP
Gynecologic oncology 2013 Nov;131(2):368-73
Gynecologic oncology 2013 Nov;131(2):368-73
Basal cytokeratin as a potential marker of low risk of invasion in ductal carcinoma in situ.
Aguiar FN, Mendes HN, Cirqueira CS, Bacchi CE, Carvalho FM
Clinics (Sao Paulo, Brazil) 2013 May;68(5):638-43
Clinics (Sao Paulo, Brazil) 2013 May;68(5):638-43
Estrogen receptor α is the major driving factor for growth in tamoxifen-resistant breast cancer and supported by HER/ERK signaling.
Thrane S, Lykkesfeldt AE, Larsen MS, Sorensen BS, Yde CW
Breast cancer research and treatment 2013 May;139(1):71-80
Breast cancer research and treatment 2013 May;139(1):71-80
Expression of steroid receptor coactivator 3 in ovarian epithelial cancer is a poor prognostic factor and a marker for platinum resistance.
Palmieri C, Gojis O, Rudraraju B, Stamp-Vincent C, Wilson D, Langdon S, Gourley C, Faratian D
British journal of cancer 2013 May 28;108(10):2039-44
British journal of cancer 2013 May 28;108(10):2039-44
Extranuclear ERα is associated with regression of T47D PKCα-overexpressing, tamoxifen-resistant breast cancer.
Perez White B, Molloy ME, Zhao H, Zhang Y, Tonetti DA
Molecular cancer 2013 May 1;12:34
Molecular cancer 2013 May 1;12:34
Risk predictors of underestimation and the need for sentinel node biopsy in patients diagnosed with ductal carcinoma in situ by preoperative needle biopsy.
Park HS, Park S, Cho J, Park JM, Kim SI, Park BW
Journal of surgical oncology 2013 Mar;107(4):388-92
Journal of surgical oncology 2013 Mar;107(4):388-92
Oestrogen increases the activity of oestrogen receptor negative breast cancer stem cells through paracrine EGFR and Notch signalling.
Harrison H, Simões BM, Rogerson L, Howell SJ, Landberg G, Clarke RB
Breast cancer research : BCR 2013 Mar 8;15(2):R21
Breast cancer research : BCR 2013 Mar 8;15(2):R21
The prognostic role of preoperative and (early) postoperatively change in CA15.3 serum levels in a single hospital cohort of primary operable breast cancers.
Brouckaert O, Laenen A, Wildiers H, Floris G, Moerman P, Van Limbergen E, Vergote I, Billen J, Christiaens MR, Neven P
Breast (Edinburgh, Scotland) 2013 Jun;22(3):254-62
Breast (Edinburgh, Scotland) 2013 Jun;22(3):254-62
Associations between the Expression of Mucins (MUC1, MUC2, MUC5AC, and MUC6) and Clinicopathologic Parameters of Human Breast Ductal Carcinomas.
Do SI, Kim K, Kim DH, Chae SW, Park YL, Park CH, Sohn JH
Journal of breast cancer 2013 Jun;16(2):152-8
Journal of breast cancer 2013 Jun;16(2):152-8
Synchronous ductal carcinoma in situ of the breast and within epithelial inclusions in an ipsilateral sentinel lymph node.
Fitzpatrick-Swallow VL, Helin H, Cane P, Pinder SE
Human pathology 2013 Jan;44(1):142-4
Human pathology 2013 Jan;44(1):142-4
Comparison of the PharmDx immunohistochemical system with standard methods for assessing estrogen and progesterone receptors in invasive carcinoma of the breast.
Gill MS, Paish EC, Ronan J, Green AR, Ellis IO, Lee AH
Applied immunohistochemistry & molecular morphology : AIMM 2013 Jan;21(1):90-3
Applied immunohistochemistry & molecular morphology : AIMM 2013 Jan;21(1):90-3
Can additional immunohistochemistry staining replace the surgical excision for the diagnosis of papillary breast lesions classified as benign on 14-gage core needle biopsy?
Koo JS, Han K, Kim MJ, Moon HJ, Kim EK, Park BW
Breast cancer research and treatment 2013 Feb;137(3):797-806
Breast cancer research and treatment 2013 Feb;137(3):797-806
TIMP1 overexpression mediates resistance of MCF-7 human breast cancer cells to fulvestrant and down-regulates progesterone receptor expression.
Bjerre C, Vinther L, Belling KC, Würtz SØ, Yadav R, Lademann U, Rigina O, Do KN, Ditzel HJ, Lykkesfeldt AE, Wang J, Nielsen HB, Brünner N, Gupta R, Schrohl AS, Stenvang J
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2013 Dec;34(6):3839-51
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2013 Dec;34(6):3839-51
Prognostic comparison of the proliferation markers (mitotic activity index, phosphohistone H3, Ki67), steroid receptors, HER2, high molecular weight cytokeratins and classical prognostic factors in T₁₋₂N₀M₀ breast cancer.
Gudlaugsson E, Klos J, Skaland I, Janssen EA, Smaaland R, Feng W, Shao Z, Malpica A, Baak JP
Polish journal of pathology : official journal of the Polish Society of Pathologists 2013 Apr;64(1):1-8
Polish journal of pathology : official journal of the Polish Society of Pathologists 2013 Apr;64(1):1-8
Prognostic comparison of the proliferation markers (mitotic activity index, phosphohistone H3, Ki67), steroid receptors, HER2, high molecular weight cytokeratins and classical prognostic factors in T₁₋₂N₀M₀ breast cancer.
Gudlaugsson E, Klos J, Skaland I, Janssen EA, Smaaland R, Feng W, Shao Z, Malpica A, Baak JP
Polish journal of pathology : official journal of the Polish Society of Pathologists 2013 Apr;64(1):1-8
Polish journal of pathology : official journal of the Polish Society of Pathologists 2013 Apr;64(1):1-8
Genomic and phenotypic profiles of two Brazilian breast cancer cell lines derived from primary human tumors.
Corrêa NC, Kuasne H, Faria JA, Seixas CC, Santos IG, Abreu FB, Nonogaki S, Rocha RM, Aparecida Borges Silva G, Gobbi H, Rogatto SR, Goes AM, Gomes DA
Oncology reports 2013 Apr;29(4):1299-307
Oncology reports 2013 Apr;29(4):1299-307
Identification of estrogen receptor dimer selective ligands reveals growth-inhibitory effects on cells that co-express ERα and ERβ.
Powell E, Shanle E, Brinkman A, Li J, Keles S, Wisinski KB, Huang W, Xu W
PloS one 2012;7(2):e30993
PloS one 2012;7(2):e30993
Proteomic analyses reveal high expression of decorin and endoplasmin (HSP90B1) are associated with breast cancer metastasis and decreased survival.
Cawthorn TR, Moreno JC, Dharsee M, Tran-Thanh D, Ackloo S, Zhu PH, Sardana G, Chen J, Kupchak P, Jacks LM, Miller NA, Youngson BJ, Iakovlev V, Guidos CJ, Vallis KA, Evans KR, McCready D, Leong WL, Done SJ
PloS one 2012;7(2):e30992
PloS one 2012;7(2):e30992
Leiomyomatosis peritonealis disseminata associated with endometriosis and multiple uterus-like mass: report of two cases.
Carvalho FM, Carvalho JP, Pereira RM, Ceccato BP Jr, Lacordia R, Baracat EC
Clinical medicine insights. Case reports 2012;5:63-8
Clinical medicine insights. Case reports 2012;5:63-8
Arginase activity in patients with breast cancer: an analysis of plasma, tumors, and its relationship with the presence of the estrogen receptor.
Perez G, Olivares IM, Rodriguez MG, Ceballos GM, Garcia Sanchez JR
Onkologie 2012;35(10):570-4
Onkologie 2012;35(10):570-4
Molecular alterations between the primary breast cancer and the subsequent locoregional/metastatic tumor.
Macfarlane R, Seal M, Speers C, Woods R, Masoudi H, Aparicio S, Chia SK
The oncologist 2012;17(2):172-8
The oncologist 2012;17(2):172-8
Accessory breast cancer occurring concurrently with bilateral primary invasive breast carcinomas: a report of two cases and literature review.
Hao JY, Yang CC, Liu FF, Yang YL, Li S, Li WD, Li YQ, Lang RG, Fan Y, Paulos E, Zhang XM, Fu L
Cancer biology & medicine 2012 Sep;9(3):197-201
Cancer biology & medicine 2012 Sep;9(3):197-201
Inverse expression of cystein-rich 61 (Cyr61/CCN1) and connective tissue growth factor (CTGF/CCN2) in borderline tumors and carcinomas of the ovary.
Bartel F, Balschun K, Gradhand E, Strauss HG, Dittmer J, Hauptmann S
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2012 Sep;31(5):405-15
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2012 Sep;31(5):405-15
The prognostic value of MARCKS-like 1 in lymph node-negative breast cancer.
Jonsdottir K, Zhang H, Jhagroe D, Skaland I, Slewa A, Björkblom B, Coffey ET, Gudlaugsson E, Smaaland R, Janssen EA, Baak JP
Breast cancer research and treatment 2012 Sep;135(2):381-90
Breast cancer research and treatment 2012 Sep;135(2):381-90
Akt expression and compartmentalization in prediction of clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab.
Grell P, Fabian P, Khoylou M, Radova L, Slaby O, Hrstka R, Vyzula R, Hajduch M, Svoboda M
International journal of oncology 2012 Oct;41(4):1204-12
International journal of oncology 2012 Oct;41(4):1204-12
Applying the 2011 St Gallen panel of prognostic markers on a large single hospital cohort of consecutively treated primary operable breast cancers.
Brouckaert O, Laenen A, Vanderhaegen J, Wildiers H, Leunen K, Amant F, Berteloot P, Smeets A, Paridaens R, Christiaens MR, Floris G, Moerman P, Van Limbergen E, Peeters S, Weltens C, Vergote I, Neven P
Annals of oncology : official journal of the European Society for Medical Oncology 2012 Oct;23(10):2578-2584
Annals of oncology : official journal of the European Society for Medical Oncology 2012 Oct;23(10):2578-2584
Correlation between HER2 gene amplification and protein overexpression through fluorescence in situ hybridization and immunohistochemistry in breast carcinoma patients.
Makroo RN, Chowdhry M, Kumar M, Srivastava P, Tyagi R, Bhadauria P, Kaul S, Sarin R, Das PK, Dua H
Indian journal of pathology & microbiology 2012 Oct-Dec;55(4):481-4
Indian journal of pathology & microbiology 2012 Oct-Dec;55(4):481-4
Histological analysis of benign breast imaging reporting and data system categories 4c and 5 breast lesions in imaging study.
Kim MJ, Kim D, Jung W, Koo JS
Yonsei medical journal 2012 Nov 1;53(6):1203-10
Yonsei medical journal 2012 Nov 1;53(6):1203-10
A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin and trastuzumab for T2 breast cancers.
Lin C, Chen DR, Chang KJ, Chang TW, Wang HC
Cancer chemotherapy and pharmacology 2012 May;69(5):1363-8
Cancer chemotherapy and pharmacology 2012 May;69(5):1363-8
The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: a histologically high-grade and clinically aggressive tumor.
Lee CH, Mariño-Enriquez A, Ou W, Zhu M, Ali RH, Chiang S, Amant F, Gilks CB, van de Rijn M, Oliva E, Debiec-Rychter M, Dal Cin P, Fletcher JA, Nucci MR
The American journal of surgical pathology 2012 May;36(5):641-53
The American journal of surgical pathology 2012 May;36(5):641-53
Increased FDG uptake in breast cancer is associated with prognostic factors.
Sanli Y, Kuyumcu S, Ozkan ZG, Işik G, Karanlik H, Guzelbey B, Turkmen C, Ozel S, Yavuz E, Mudun A
Annals of nuclear medicine 2012 May;26(4):345-50
Annals of nuclear medicine 2012 May;26(4):345-50
TRADD contributes to tumour suppression by regulating ULF-dependent p19Arf ubiquitylation.
Chio II, Sasaki M, Ghazarian D, Moreno J, Done S, Ueda T, Inoue S, Chang YL, Chen NJ, Mak TW
Nature cell biology 2012 May 6;14(6):625-33
Nature cell biology 2012 May 6;14(6):625-33
Estrogen receptor alpha mediates progestin-induced mammary tumor growth by interacting with progesterone receptors at the cyclin D1/MYC promoters.
Giulianelli S, Vaqué JP, Soldati R, Wargon V, Vanzulli SI, Martins R, Zeitlin E, Molinolo AA, Helguero LA, Lamb CA, Gutkind JS, Lanari C
Cancer research 2012 May 1;72(9):2416-27
Cancer research 2012 May 1;72(9):2416-27
A 10-year follow-up of triple-negative breast cancer patients in Taiwan.
Lin C, Chien SY, Kuo SJ, Chen LS, Chen ST, Lai HW, Chang TW, Chen DR
Japanese journal of clinical oncology 2012 Mar;42(3):161-7
Japanese journal of clinical oncology 2012 Mar;42(3):161-7
Concurrent endometrial intraepithelial carcinoma (EIC) and serous ovarian cancer: can EIC be seen as the precursor lesion?
Roelofsen T, van Kempen LC, van der Laak JA, van Ham MA, Bulten J, Massuger LF
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2012 Mar;22(3):457-64
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2012 Mar;22(3):457-64
MiR-34b is associated with clinical outcome in triple-negative breast cancer patients.
Svoboda M, Sana J, Redova M, Navratil J, Palacova M, Fabian P, Slaby O, Vyzula R
Diagnostic pathology 2012 Mar 22;7:31
Diagnostic pathology 2012 Mar 22;7:31
Clinicopathologic features of the mixed epithelial and mesenchymal type metaplastic breast carcinoma with myoepithelial differentiation in a subset of six cases.
Yigit S, Pehlivan FS, Evcim G, Etit D
Pathology, research and practice 2012 Mar 15;208(3):147-50
Pathology, research and practice 2012 Mar 15;208(3):147-50
Vaginal superficial myofibroblastoma: a rare mesenchymal tumor of the lower female genital tract and a study of its association with viral infection.
Liu JL, Su TC, Shen KH, Lin SH, Wang HK, Hsu JC, Chen CJ
Medical molecular morphology 2012 Jun;45(2):110-4
Medical molecular morphology 2012 Jun;45(2):110-4
The hormone receptor, human epidermal growth factor receptor 2, and molecular subtype status of individual tumor foci in multifocal/multicentric invasive ductal carcinoma of breast.
Choi Y, Kim EJ, Seol H, Lee HE, Jang MJ, Kim SM, Kim JH, Kim SW, Choe G, Park SY
Human pathology 2012 Jan;43(1):48-55
Human pathology 2012 Jan;43(1):48-55
Reconstruction of nuclear receptor network reveals that NR2E3 is a novel upstream regulator of ESR1 in breast cancer.
Park YY, Kim K, Kim SB, Hennessy BT, Kim SM, Park ES, Lim JY, Li J, Lu Y, Gonzalez-Angulo AM, Jeong W, Mills GB, Safe S, Lee JS
EMBO molecular medicine 2012 Jan;4(1):52-67
EMBO molecular medicine 2012 Jan;4(1):52-67
Routine pathologic parameters can predict Oncotype DX recurrence scores in subsets of ER positive patients: who does not always need testing?
Allison KH, Kandalaft PL, Sitlani CM, Dintzis SM, Gown AM
Breast cancer research and treatment 2012 Jan;131(2):413-24
Breast cancer research and treatment 2012 Jan;131(2):413-24
A new case of primary signet-ring cell carcinoma of the cervix with prominent endometrial and myometrial involvement: Immunohistochemical and molecular studies and review of the literature.
Giordano G, Pizzi S, Berretta R, D'Adda T
World journal of surgical oncology 2012 Jan 11;10:7
World journal of surgical oncology 2012 Jan 11;10:7
Cytoplasmic estrogen receptor in breast cancer.
Welsh AW, Lannin DR, Young GS, Sherman ME, Figueroa JD, Henry NL, Ryden L, Kim C, Love RR, Schiff R, Rimm DL
Clinical cancer research : an official journal of the American Association for Cancer Research 2012 Jan 1;18(1):118-26
Clinical cancer research : an official journal of the American Association for Cancer Research 2012 Jan 1;18(1):118-26
Characteristics and outcomes according to molecular subtypes of breast cancer as classified by a panel of four biomarkers using immunohistochemistry.
Park S, Koo JS, Kim MS, Park HS, Lee JS, Lee JS, Kim SI, Park BW
Breast (Edinburgh, Scotland) 2012 Feb;21(1):50-7
Breast (Edinburgh, Scotland) 2012 Feb;21(1):50-7
Breast cancers presenting luminal B subtype features show higher discordant human epidermal growth factor receptor 2 results between immunohistochemistry and fluorescence in situ hybridization.
Park S, Park HS, Koo JS, Yang WI, Kim SI, Park BW
Cancer 2012 Feb 15;118(4):914-23
Cancer 2012 Feb 15;118(4):914-23
Heterogeneity of ERα and ErbB2 Status in Cell Lines and Circulating Tumor Cells of Metastatic Breast Cancer Patients.
Bock C, Rack B, Kuhn C, Hofmann S, Finkenzeller C, Jäger B, Jeschke U, Doisneau-Sixou SF
Translational oncology 2012 Dec;5(6):475-85
Translational oncology 2012 Dec;5(6):475-85
Heterogeneity of ERα and ErbB2 Status in Cell Lines and Circulating Tumor Cells of Metastatic Breast Cancer Patients.
Bock C, Rack B, Kuhn C, Hofmann S, Finkenzeller C, Jäger B, Jeschke U, Doisneau-Sixou SF
Translational oncology 2012 Dec;5(6):475-85
Translational oncology 2012 Dec;5(6):475-85
Homeodomain-interacting protein kinase 1 (HIPK1) expression in breast cancer tissues.
Park BW, Park S, Koo JS, Kim SI, Park JM, Cho JH, Park HS
Japanese journal of clinical oncology 2012 Dec;42(12):1138-45
Japanese journal of clinical oncology 2012 Dec;42(12):1138-45
Quantitative assessment of effect of preanalytic cold ischemic time on protein expression in breast cancer tissues.
Neumeister VM, Anagnostou V, Siddiqui S, England AM, Zarrella ER, Vassilakopoulou M, Parisi F, Kluger Y, Hicks DG, Rimm DL
Journal of the National Cancer Institute 2012 Dec 5;104(23):1815-24
Journal of the National Cancer Institute 2012 Dec 5;104(23):1815-24
FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma.
Brunello E, Brunelli M, Bogina G, Caliò A, Manfrin E, Nottegar A, Vergine M, Molino A, Bria E, Massari F, Tortora G, Cingarlini S, Pedron S, Chilosi M, Zamboni G, Miller K, Martignoni G, Bonetti F
Journal of experimental & clinical cancer research : CR 2012 Dec 27;31(1):103
Journal of experimental & clinical cancer research : CR 2012 Dec 27;31(1):103
Cytologic features of triple-negative breast carcinoma.
Bonzanini M, Morelli L, Bonandini EM, Leonardi E, Pertile R, Dalla Palma P
Cancer cytopathology 2012 Dec 25;120(6):401-9
Cancer cytopathology 2012 Dec 25;120(6):401-9
The pathologic characteristics of breast cancer in China and its shift during 1999-2008: a national-wide multicenter cross-sectional image over 10 years.
Zheng S, Bai JQ, Li J, Fan JH, Pang Y, Song QK, Huang R, Yang HJ, Xu F, Lu N, Qiao YL
International journal of cancer 2012 Dec 1;131(11):2622-31
International journal of cancer 2012 Dec 1;131(11):2622-31
Prediction of the shrinking rate of uterine leiomyoma nodules using needle biopsy specimens.
Kasai M, Ichimura T, Kawamura N, Sumikura T, Matsuda M, Asano C, Sumi T, Ishiko O
Fertility and sterility 2012 Aug;98(2):440-3
Fertility and sterility 2012 Aug;98(2):440-3
Neovascularization evaluated by CD105 correlates well with prognostic factors in breast cancers.
Rau KM, Huang CC, Chiu TJ, Chen YY, Lu CC, Liu CT, Pei SN, Wei YC
Experimental and therapeutic medicine 2012 Aug;4(2):231-236
Experimental and therapeutic medicine 2012 Aug;4(2):231-236
Invasive lobular carcinoma with extracellular mucin as a distinct variant of lobular carcinoma: a case report.
Haltas H, Bayrak R, Yenidunya S, Kosehan D, Sen M, Akin K
Diagnostic pathology 2012 Aug 6;7:91
Diagnostic pathology 2012 Aug 6;7:91
mTOR in breast cancer: differential expression in triple-negative and non-triple-negative tumors.
Walsh S, Flanagan L, Quinn C, Evoy D, McDermott EW, Pierce A, Duffy MJ
Breast (Edinburgh, Scotland) 2012 Apr;21(2):178-82
Breast (Edinburgh, Scotland) 2012 Apr;21(2):178-82
Stromal caveolin-1 expression in breast carcinoma. Correlation with early tumor recurrence and clinical outcome.
El-Gendi SM, Mostafa MF, El-Gendi AM
Pathology oncology research : POR 2012 Apr;18(2):459-69
Pathology oncology research : POR 2012 Apr;18(2):459-69
KX-01, a novel Src kinase inhibitor directed toward the peptide substrate site, synergizes with tamoxifen in estrogen receptor α positive breast cancer.
Anbalagan M, Carrier L, Glodowski S, Hangauer D, Shan B, Rowan BG
Breast cancer research and treatment 2012 Apr;132(2):391-409
Breast cancer research and treatment 2012 Apr;132(2):391-409
Implementation of TMA and digitalization in routine diagnostics of breast pathology.
Rossing HH, Talman ML, Laenkholm AV, Wielenga VT
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2012 Apr;120(4):341-7
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2012 Apr;120(4):341-7
Clinical significance of KISS1 protein expression for brain invasion and metastasis.
Ulasov IV, Kaverina NV, Pytel P, Thaci B, Liu F, Hurst DR, Welch DR, Sattar HA, Olopade OI, Baryshnikov AY, Kadagidze ZG, Lesniak MS
Cancer 2012 Apr 15;118(8):2096-105
Cancer 2012 Apr 15;118(8):2096-105
Clinical and pathological features of breast cancer associated with the pathological complete response to anthracycline-based neoadjuvant chemotherapy.
Keskin S, Muslumanoglu M, Saip P, Karanlık H, Guveli M, Pehlivan E, Aydoğan F, Eralp Y, Aydıner A, Yavuz E, Ozmen V, Igci A, Topuz E
Oncology 2011;81(1):30-8
Oncology 2011;81(1):30-8
Tumor topoisomerase II alpha status and response to anthracycline-based neoadjuvant chemotherapy in breast cancer.
Nikolényi A, Sükösd F, Kaizer L, Csörgo E, Vörös A, Uhercsák G, Ormándi K, Lázár G, Thurzó L, Brodowicz T, Kahán Z
Oncology 2011;80(3-4):269-77
Oncology 2011;80(3-4):269-77
Evaluation of prognostic factors in stage IIA breast tumors and their correlation with mortality risk.
Carvalho ST, Stiepcich MM, Fregnani JH, Nonogaki S, Rocha R, Soares FA
Clinics (Sao Paulo, Brazil) 2011;66(4):607-12
Clinics (Sao Paulo, Brazil) 2011;66(4):607-12
Evaluation of prognostic factors in stage IIA breast tumors and their correlation with mortality risk.
Carvalho ST, Stiepcich MM, Fregnani JH, Nonogaki S, Rocha R, Soares FA
Clinics (Sao Paulo, Brazil) 2011;66(4):607-12
Clinics (Sao Paulo, Brazil) 2011;66(4):607-12
Analysis of peptidyl-propyl-cis/trans isomerase 1 (PIN1) gene -842(G > C) and -667(T > C) polymorphic variants in relation to breast cancer risk and clinico-pathological parameters.
Naidu R, Har YC, Taib NA
Scandinavian journal of clinical and laboratory investigation 2011 Oct;71(6):500-6
Scandinavian journal of clinical and laboratory investigation 2011 Oct;71(6):500-6
Molecular phenotypes of matched in situ and invasive components of breast carcinomas.
Martins D, Sousa B, Lopes N, Gomes M, Veronese L, Albergaria A, Paredes J, Schmitt F
Human pathology 2011 Oct;42(10):1438-46
Human pathology 2011 Oct;42(10):1438-46
Investigation of galectin-3 and heparanase in endometrioid and serous carcinomas of the endometrium and correlation with known predictors of survival.
Ege CB, Akbulut M, Zekioğlu O, Ozdemir N
Archives of gynecology and obstetrics 2011 Nov;284(5):1231-9
Archives of gynecology and obstetrics 2011 Nov;284(5):1231-9
Androgen receptor expression in primary breast cancer and its predictive and prognostic value in patients treated with neoadjuvant chemotherapy.
Loibl S, Müller BM, von Minckwitz G, Schwabe M, Roller M, Darb-Esfahani S, Ataseven B, du Bois A, Fissler-Eckhoff A, Gerber B, Kulmer U, Alles JU, Mehta K, Denkert C
Breast cancer research and treatment 2011 Nov;130(2):477-87
Breast cancer research and treatment 2011 Nov;130(2):477-87
May metaplastic breast carcinomas be actually basal-like carcinoma? Further evidence study with its ultrastructure and survival analysis.
Wang H, Guan B, Shi Q, Ma H, Zhou H, Wang X, Zhou X
Medical oncology (Northwood, London, England) 2011 Mar;28(1):42-50
Medical oncology (Northwood, London, England) 2011 Mar;28(1):42-50
Quantitative determination of estrogen receptor, progesterone receptor, and HER2 mRNA in formalin-fixed paraffin-embedded tissue--a new option for predictive biomarker assessment in breast cancer.
Müller BM, Kronenwett R, Hennig G, Euting H, Weber K, Bohmann K, Weichert W, Altmann G, Roth C, Winzer KJ, Kristiansen G, Petry C, Dietel M, Denkert C
Diagnostic molecular pathology : the American journal of surgical pathology, part B 2011 Mar;20(1):1-10
Diagnostic molecular pathology : the American journal of surgical pathology, part B 2011 Mar;20(1):1-10
The feasibility of endoscopy-assisted breast conservation surgery for patients with early breast cancer.
Park HS, Lee JS, Lee JS, Park S, Kim SI, Park BW
Journal of breast cancer 2011 Mar;14(1):52-7
Journal of breast cancer 2011 Mar;14(1):52-7
Sclerosing polycystic adenosis of the parotid gland: report of a bifocal, paucicystic variant with ductal carcinoma in situ and pronounced stromal distortion mimicking invasive carcinoma.
Petersson F, Tan PH, Hwang JS
Head and neck pathology 2011 Jun;5(2):188-92
Head and neck pathology 2011 Jun;5(2):188-92
Unusual finding of endocervical-like mucinous epithelium in continuity with urothelium in endocervicosis of the urinary bladder.
Cheah PL, Looi LM, Lee GE, Teoh KH, Mun KS, Nazarina AR
Diagnostic pathology 2011 Jun 23;6:56
Diagnostic pathology 2011 Jun 23;6:56
Cytokeratin 5 positive cells represent a steroid receptor negative and therapy resistant subpopulation in luminal breast cancers.
Kabos P, Haughian JM, Wang X, Dye WW, Finlayson C, Elias A, Horwitz KB, Sartorius CA
Breast cancer research and treatment 2011 Jul;128(1):45-55
Breast cancer research and treatment 2011 Jul;128(1):45-55
Amplification of the prolactin receptor gene in mammary lobular neoplasia.
Tran-Thanh D, Arneson NC, Pintilie M, Deliallisi A, Warren KS, Bane A, Done SJ
Breast cancer research and treatment 2011 Jul;128(1):31-40
Breast cancer research and treatment 2011 Jul;128(1):31-40
Promoter CpG island hypermethylation during breast cancer progression.
Park SY, Kwon HJ, Lee HE, Ryu HS, Kim SW, Kim JH, Kim IA, Jung N, Cho NY, Kang GH
Virchows Archiv : an international journal of pathology 2011 Jan;458(1):73-84
Virchows Archiv : an international journal of pathology 2011 Jan;458(1):73-84
Prognostic significance of triple negative breast cancer at tumor size 1 cm and smaller.
Lai HW, Kuo SJ, Chen LS, Chi CW, Chen ST, Chang TW, Chen DR
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2011 Jan;37(1):18-24
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2011 Jan;37(1):18-24
Estrogen receptor expression in sporadic vestibular schwannomas.
Brown CM, Ahmad ZK, Ryan AF, Doherty JK
Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2011 Jan;32(1):158-62
Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2011 Jan;32(1):158-62
A case of prostatic adenocarcinoma with aberrant p63 expression: presentation with detailed immunohistochemical study and FISH analysis.
Baydar DE, Kulac I, Gurel B, De Marzo A
International journal of surgical pathology 2011 Feb;19(1):131-6
International journal of surgical pathology 2011 Feb;19(1):131-6
Estrogen-independent actions of environmentally relevant AhR-agonists in human endometrial epithelial cells.
Willing C, Peich M, Danescu A, Kehlen A, Fowler PA, Hombach-Klonisch S
Molecular human reproduction 2011 Feb;17(2):115-26
Molecular human reproduction 2011 Feb;17(2):115-26
Dietary patterns and risk of breast cancer.
Baglietto L, Krishnan K, Severi G, Hodge A, Brinkman M, English DR, McLean C, Hopper JL, Giles GG
British journal of cancer 2011 Feb 1;104(3):524-31
British journal of cancer 2011 Feb 1;104(3):524-31
Effects of long-term storage on the detection of proteins, DNA, and mRNA in tissue microarray slides.
Karlsson C, Karlsson MG
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2011 Dec;59(12):1113-21
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2011 Dec;59(12):1113-21
Correlation of histologic grade with other clinicopathological parameters, intrinsic subtype, and patients' clinical outcome in Taiwanese women.
Chen ST, Lai HW, Tseng HS, Chen LS, Kuo SJ, Chen DR
Japanese journal of clinical oncology 2011 Dec;41(12):1327-35
Japanese journal of clinical oncology 2011 Dec;41(12):1327-35
Recurrence of benign meningiomas: predictive value of proliferative index, BCL2, p53, hormonal receptors and HER2 expression.
Abdelzaher E, El-Gendi SM, Yehya A, Gowil AG
British journal of neurosurgery 2011 Dec;25(6):707-13
British journal of neurosurgery 2011 Dec;25(6):707-13
Dendritic cells treated with HPV16mE7 in a three-dimensional model promote the secretion of IL-12p70 and IFN-γ.
Wang YT, Li W, Liu Q, Guan X, Hu J
Experimental and molecular pathology 2011 Aug;91(1):325-30
Experimental and molecular pathology 2011 Aug;91(1):325-30
Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers.
Park S, Koo JS, Kim MS, Park HS, Lee JS, Lee JS, Kim SI, Park BW, Lee KS
Annals of oncology : official journal of the European Society for Medical Oncology 2011 Aug;22(8):1755-62
Annals of oncology : official journal of the European Society for Medical Oncology 2011 Aug;22(8):1755-62
Serial changes in the expression of breast cancer-related proteins in response to neoadjuvant chemotherapy.
Chuah BY, Putti T, Salto-Tellez M, Charlton A, Iau P, Buhari SA, Wong CI, Tan SH, Wong AL, Chan CW, Goh BC, Lee SC
Annals of oncology : official journal of the European Society for Medical Oncology 2011 Aug;22(8):1748-54
Annals of oncology : official journal of the European Society for Medical Oncology 2011 Aug;22(8):1748-54
D2-40/p63 defined lymph vessel invasion has additional prognostic value in highly proliferating operable node negative breast cancer patients.
Gudlaugsson E, Skaland I, Undersrud E, Janssen EA, Søiland H, Baak JP
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2011 Apr;24(4):502-11
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2011 Apr;24(4):502-11
Factors affecting estrogen receptor status in a multiracial Asian country: an analysis of 3557 cases.
Yip CH, Pathy NB, Uiterwaal CS, Taib NA, Tan GH, Mun KS, Choo WY, Rhodes A
Breast (Edinburgh, Scotland) 2011 Apr;20 Suppl 2:S60-4
Breast (Edinburgh, Scotland) 2011 Apr;20 Suppl 2:S60-4
Mutations in the epidermal growth factor receptor (EGFR) gene in triple negative breast cancer: possible implications for targeted therapy.
Teng YH, Tan WJ, Thike AA, Cheok PY, Tse GM, Wong NS, Yip GW, Bay BH, Tan PH
Breast cancer research : BCR 2011 Apr 1;13(2):R35
Breast cancer research : BCR 2011 Apr 1;13(2):R35
Molecular subtypes and tumor response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.
Kim SI, Sohn J, Koo JS, Park SH, Park HS, Park BW
Oncology 2010;79(5-6):324-30
Oncology 2010;79(5-6):324-30
Primary adenocarcinoma of the rectovaginal septum arising in pregnancy in the absence of endometriosis.
Giordano G, Bersiga A, Marchetti G, Melpignano M
European journal of gynaecological oncology 2010;31(2):211-3
European journal of gynaecological oncology 2010;31(2):211-3
Low-grade salivary duct carcinoma of the parotid gland: report of a case with immunohistochemical analysis.
Kusafuka K, Itoh H, Sugiyama C, Nakajima T
Medical molecular morphology 2010 Sep;43(3):178-84
Medical molecular morphology 2010 Sep;43(3):178-84
Clinicopathologic features of 2 new cases of uterine tumors resembling ovarian sex cord tumors.
Giordano G, Lombardi M, Brigati F, Mancini C, Silini EM
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2010 Sep;29(5):459-67
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2010 Sep;29(5):459-67
Prolactin and oestrogen synergistically regulate gene expression and proliferation of breast cancer cells.
Rasmussen LM, Frederiksen KS, Din N, Galsgaard E, Christensen L, Berchtold MW, Panina S
Endocrine-related cancer 2010 Sep;17(3):809-22
Endocrine-related cancer 2010 Sep;17(3):809-22
The reliability of rabbit monoclonal antibodies in the immunohistochemical assessment of estrogen receptors, progesterone receptors, and HER2 in human breast carcinomas.
Rhodes A, Sarson J, Assam EE, Dean SJ, Cribb EC, Parker A
American journal of clinical pathology 2010 Oct;134(4):621-32
American journal of clinical pathology 2010 Oct;134(4):621-32
Human epidermal growth factor receptor 2 assessment in a case-control study: comparison of fluorescence in situ hybridization and quantitative reverse transcription polymerase chain reaction performed by central laboratories.
Baehner FL, Achacoso N, Maddala T, Shak S, Quesenberry CP Jr, Goldstein LC, Gown AM, Habel LA
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 Oct 1;28(28):4300-6
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 Oct 1;28(28):4300-6
Adenoid cystic carcinomas of the breast have low Topo IIα expression but frequently overexpress EGFR protein without EGFR gene amplification.
Vranic S, Frkovic-Grazio S, Lamovec J, Serdarevic F, Gurjeva O, Palazzo J, Bilalovic N, Lee LM, Gatalica Z
Human pathology 2010 Nov;41(11):1617-23
Human pathology 2010 Nov;41(11):1617-23
The quantitative detection of total HER2 load by quantum dots and the identification of a new subtype of breast cancer with different 5-year prognosis.
Chen C, Xia HS, Gong YP, Peng J, Peng CW, Hu MB, Zhu XB, Pang DW, Sun SR, Li Y
Biomaterials 2010 Nov;31(33):8818-25
Biomaterials 2010 Nov;31(33):8818-25
Effect of neoadjuvant anthracycline-taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study.
Huober J, von Minckwitz G, Denkert C, Tesch H, Weiss E, Zahm DM, Belau A, Khandan F, Hauschild M, Thomssen C, Högel B, Darb-Esfahani S, Mehta K, Loibl S
Breast cancer research and treatment 2010 Nov;124(1):133-40
Breast cancer research and treatment 2010 Nov;124(1):133-40
Tissue-specific pathways for estrogen regulation of ovarian cancer growth and metastasis.
Spillman MA, Manning NG, Dye WW, Sartorius CA, Post MD, Harrell JC, Jacobsen BM, Horwitz KB
Cancer research 2010 Nov 1;70(21):8927-36
Cancer research 2010 Nov 1;70(21):8927-36
Prospective multicenter comparison of proliferation and other prognostic factors in lymph node negative lobular invasive breast cancer.
Gudlaugsson E, Skaland I, Janssen EA, van Diest PJ, Voorhorst FJ, Kjellevold K, zur Hausen A, Baak JP
Breast cancer research and treatment 2010 May;121(1):35-40
Breast cancer research and treatment 2010 May;121(1):35-40
Molecular characterization of breast cancer in young Brazilian women.
Carvalho LV, Pereira EM, Frappart L, Boniol M, Bernardo WM, Tarricone V, Tavtigian S, Southey MC
Revista da Associacao Medica Brasileira (1992) 2010 May-Jun;56(3):278-87
Revista da Associacao Medica Brasileira (1992) 2010 May-Jun;56(3):278-87
Molecular characterization of breast cancer in young Brazilian women.
Carvalho LV, Pereira EM, Frappart L, Boniol M, Bernardo WM, Tarricone V, Tavtigian S, Southey MC
Revista da Associacao Medica Brasileira (1992) 2010 May-Jun;56(3):278-87
Revista da Associacao Medica Brasileira (1992) 2010 May-Jun;56(3):278-87
Immunohistochemical expression of estrogen and progesterone receptors in endometrial polyps and its relationship to clinical parameters.
Gul A, Ugur M, Iskender C, Zulfikaroglu E, Ozaksit G
Archives of gynecology and obstetrics 2010 Mar;281(3):479-83
Archives of gynecology and obstetrics 2010 Mar;281(3):479-83
Expression of androgen receptors in primary breast cancer.
Park S, Koo J, Park HS, Kim JH, Choi SY, Lee JH, Park BW, Lee KS
Annals of oncology : official journal of the European Society for Medical Oncology 2010 Mar;21(3):488-492
Annals of oncology : official journal of the European Society for Medical Oncology 2010 Mar;21(3):488-492
Immunohistochemical expression of estrogen receptor in adenocarcinomas of the lung: the antibody factor.
Gomez-Fernandez C, Mejias A, Walker G, Nadji M
Applied immunohistochemistry & molecular morphology : AIMM 2010 Mar;18(2):137-41
Applied immunohistochemistry & molecular morphology : AIMM 2010 Mar;18(2):137-41
p16INK4a expression in basal-like breast carcinoma.
Bohn OL, Fuertes-Camilo M, Navarro L, Saldivar J, Sanchez-Sosa S
International journal of clinical and experimental pathology 2010 Jun 30;3(6):600-7
International journal of clinical and experimental pathology 2010 Jun 30;3(6):600-7
The new platinum(IV) derivative LA-12 shows stronger inhibitory effect on Hsp90 function compared to cisplatin.
Kvardova V, Hrstka R, Walerych D, Muller P, Matoulkova E, Hruskova V, Stelclova D, Sova P, Vojtesek B
Molecular cancer 2010 Jun 15;9:147
Molecular cancer 2010 Jun 15;9:147
High-grade endometrial carcinoma: serous and grade 3 endometrioid carcinomas have different immunophenotypes and outcomes.
Alkushi A, Köbel M, Kalloger SE, Gilks CB
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2010 Jul;29(4):343-50
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2010 Jul;29(4):343-50
Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor-positive human breast cancer.
Miller TW, Hennessy BT, González-Angulo AM, Fox EM, Mills GB, Chen H, Higham C, García-Echeverría C, Shyr Y, Arteaga CL
The Journal of clinical investigation 2010 Jul;120(7):2406-13
The Journal of clinical investigation 2010 Jul;120(7):2406-13
Citraconic anhydride: a new antigen retrieval solution.
Leong AS, Haffajee Z
Pathology 2010 Jan;42(1):77-81
Pathology 2010 Jan;42(1):77-81
A class discovery and class prediction approach to histopathological classification of mammographic screen detected columnar cell lesions of the breast.
Pathmanathan N, Salisbury EL, Provan PJ, Bilous AM, Byth K, Milliken JS, Clarke CL, Balleine RL
Pathology 2010 Jan;42(1):28-36
Pathology 2010 Jan;42(1):28-36
Triple-negative breast cancer: clinicopathological characteristics and relationship with basal-like breast cancer.
Thike AA, Cheok PY, Jara-Lazaro AR, Tan B, Tan P, Tan PH
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2010 Jan;23(1):123-33
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2010 Jan;23(1):123-33
Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients.
Liu S, Chia SK, Mehl E, Leung S, Rajput A, Cheang MC, Nielsen TO
Breast cancer research and treatment 2010 Jan;119(1):53-61
Breast cancer research and treatment 2010 Jan;119(1):53-61
Prognostic significance of Dicer expression in ovarian cancer-link to global microRNA changes and oestrogen receptor expression.
Faggad A, Budczies J, Tchernitsa O, Darb-Esfahani S, Sehouli J, Müller BM, Wirtz R, Chekerov R, Weichert W, Sinn B, Mucha C, Elwali NE, Schäfer R, Dietel M, Denkert C
The Journal of pathology 2010 Feb;220(3):382-91
The Journal of pathology 2010 Feb;220(3):382-91
A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers.
Hennessy BT, Lu Y, Gonzalez-Angulo AM, Carey MS, Myhre S, Ju Z, Davies MA, Liu W, Coombes K, Meric-Bernstam F, Bedrosian I, McGahren M, Agarwal R, Zhang F, Overgaard J, Alsner J, Neve RM, Kuo WL, Gray JW, Borresen-Dale AL, Mills GB
Clinical proteomics 2010 Dec;6(4):129-51
Clinical proteomics 2010 Dec;6(4):129-51
Clinicopathological and immunohistochemical analysis of sclerosing stromal tumours of the ovary.
Zekioglu O, Ozdemir N, Terek C, Ozsaran A, Dikmen Y
Archives of gynecology and obstetrics 2010 Dec;282(6):671-6
Archives of gynecology and obstetrics 2010 Dec;282(6):671-6
Biologic profiling of lymph node negative breast cancers by means of microRNA expression.
Janssen EA, Slewa A, Gudlaugsson E, Jonsdottir K, Skaland I, Søiland H, Baak JP
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2010 Dec;23(12):1567-76
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2010 Dec;23(12):1567-76
Clinicopathological significance of calreticulin in breast invasive ductal carcinoma.
Lwin ZM, Guo C, Salim A, Yip GW, Chew FT, Nan J, Thike AA, Tan PH, Bay BH
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2010 Dec;23(12):1559-66
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2010 Dec;23(12):1559-66
Papillary apocrine metaplasia and columnar cell lesion with atypia: is there a shared common pathway?
Kosemehmetoglu K, Guler G
Annals of diagnostic pathology 2010 Dec;14(6):425-31
Annals of diagnostic pathology 2010 Dec;14(6):425-31
An illegitimate microRNA target site within the 3' UTR of MDM4 affects ovarian cancer progression and chemosensitivity.
Wynendaele J, Böhnke A, Leucci E, Nielsen SJ, Lambertz I, Hammer S, Sbrzesny N, Kubitza D, Wolf A, Gradhand E, Balschun K, Braicu I, Sehouli J, Darb-Esfahani S, Denkert C, Thomssen C, Hauptmann S, Lund A, Marine JC, Bartel F
Cancer research 2010 Dec 1;70(23):9641-9
Cancer research 2010 Dec 1;70(23):9641-9
The pro-metastatic protein anterior gradient-2 predicts poor prognosis in tamoxifen-treated breast cancers.
Hrstka R, Nenutil R, Fourtouna A, Maslon MM, Naughton C, Langdon S, Murray E, Larionov A, Petrakova K, Muller P, Dixon MJ, Hupp TR, Vojtesek B
Oncogene 2010 Aug 26;29(34):4838-47
Oncogene 2010 Aug 26;29(34):4838-47
Human mammary fibroblasts stimulate invasion of breast cancer cells in a three-dimensional culture and increase stroma development in mouse xenografts.
Olsen CJ, Moreira J, Lukanidin EM, Ambartsumian NS
BMC cancer 2010 Aug 19;10:444
BMC cancer 2010 Aug 19;10:444
Assessment of the tumorigenesis and drug susceptibility of three new canine mammary tumor cell lines.
Chang CY, Chiou PP, Chen WJ, Li YH, Yiu JC, Cheng YH, Chen SD, Lin CT, Lai YS
Research in veterinary science 2010 Apr;88(2):285-93
Research in veterinary science 2010 Apr;88(2):285-93
Protein and gene expression of estrogen receptor alpha and nuclear morphology of two breast cancer cell lines after different fixation methods.
Nykänen M, Kuopio T
Experimental and molecular pathology 2010 Apr;88(2):265-71
Experimental and molecular pathology 2010 Apr;88(2):265-71
COX-2 expression does not correlate with microvessel density in breast cancer.
Thorat MA, Mehrotra S, Morimiya A, Badve S
Pathobiology : journal of immunopathology, molecular and cellular biology 2009;76(1):39-44
Pathobiology : journal of immunopathology, molecular and cellular biology 2009;76(1):39-44
Evaluation of estrogen treatment in an immunodeficient mouse endometriosis model.
Colette S, Defrère S, Lousse JC, Van Langendonckt A, Loumaye E, Donnez J
Gynecologic and obstetric investigation 2009;68(4):262-8
Gynecologic and obstetric investigation 2009;68(4):262-8
Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients.
Søiland H, Skaland I, Varhaug JE, Kørner H, Janssen EA, Gudlaugsson E, Baak JP, Søreide JA
Acta oncologica (Stockholm, Sweden) 2009;48(4):514-21
Acta oncologica (Stockholm, Sweden) 2009;48(4):514-21
RET finger protein expression in invasive breast carcinoma: relationship between RFP and ErbB2 expression.
Tezel GG, Uner A, Yildiz I, Guler G, Takahashi M
Pathology, research and practice 2009;205(6):403-8
Pathology, research and practice 2009;205(6):403-8
Declining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community setting.
Habel LA, Achacoso NS, Haque R, Nekhlyudov L, Fletcher SW, Schnitt SJ, Collins LC, Geiger AM, Puligandla B, Acton L, Quesenberry CP Jr
Breast cancer research : BCR 2009;11(6):R85
Breast cancer research : BCR 2009;11(6):R85
Identification of biology-based breast cancer types with distinct predictive and prognostic features: role of steroid hormone and HER2 receptor expression in patients treated with neoadjuvant anthracycline/taxane-based chemotherapy.
Darb-Esfahani S, Loibl S, Müller BM, Roller M, Denkert C, Komor M, Schlüns K, Blohmer JU, Budczies J, Gerber B, Noske A, du Bois A, Weichert W, Jackisch C, Dietel M, Richter K, Kaufmann M, von Minckwitz G
Breast cancer research : BCR 2009;11(5):R69
Breast cancer research : BCR 2009;11(5):R69
Gene expression profiling of the tumor microenvironment during breast cancer progression.
Ma XJ, Dahiya S, Richardson E, Erlander M, Sgroi DC
Breast cancer research : BCR 2009;11(1):R7
Breast cancer research : BCR 2009;11(1):R7
Immunohistochemical analysis of ER, PR, Her2 and CK5/6 in infiltrative breast carcinomas in Indian patients.
Munjal K, Ambaye A, Evans MF, Mitchell J, Nandedkar S, Cooper K
Asian Pacific journal of cancer prevention : APJCP 2009;10(5):773-8
Asian Pacific journal of cancer prevention : APJCP 2009;10(5):773-8
There are no estrogen and progesterone receptors in cerebral cavernomas: a preliminary immunohistochemical study.
Kaya AH, Ulus A, Bayri Y, Topal A, Gun S, Kandemir B, Dagcinar A, Senel A, Iyigun O
Surgical neurology 2009 Sep;72(3):263-5; discussion 265
Surgical neurology 2009 Sep;72(3):263-5; discussion 265
Expression of KAI1/CD82 in distant metastases from estrogen receptor-negative breast cancer.
Christgen M, Christgen H, Heil C, Krech T, Länger F, Kreipe H, Lehmann U
Cancer science 2009 Sep;100(9):1767-71
Cancer science 2009 Sep;100(9):1767-71
Reduced prediagnostic 25-hydroxyvitamin D levels in women with breast cancer: a nested case-control study.
Rejnmark L, Tietze A, Vestergaard P, Buhl L, Lehbrink M, Heickendorff L, Mosekilde L
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009 Oct;18(10):2655-60
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009 Oct;18(10):2655-60
Vessel density assessed by endoglin expression in breast carcinomas with different expression profiles.
Lopes N, Sousa B, Vieira D, Milanezi F, Schmitt F
Histopathology 2009 Nov;55(5):594-9
Histopathology 2009 Nov;55(5):594-9
Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs).
Locati LD, Perrone F, Losa M, Mela M, Casieri P, Orsenigo M, Cortelazzi B, Negri T, Tamborini E, Quattrone P, Bossi P, Rinaldi G, Bergamini C, Calderone RG, Liberatoscioli C, Licitra L
Oral oncology 2009 Nov;45(11):986-90
Oral oncology 2009 Nov;45(11):986-90
Cytological criteria to predict basal phenotype of breast carcinomas.
Dufloth RM, Alves JM, Martins D, Vieira DS, Chikota H, Zeferino LC, Schmitt F
Diagnostic cytopathology 2009 Nov;37(11):809-14
Diagnostic cytopathology 2009 Nov;37(11):809-14
Synchronous presentation of uterine leiomyosarcoma and retroperitoneal liposarcoma: analysis by comparative genomic hybridization and review of the literature.
Chen HK, Huang HY, Li CF, Ko SF, Changchien CC, Chen WJ, Huang CC
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2009 Nov;28(6):535-40
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2009 Nov;28(6):535-40
Short-term outcome of primary operated early breast cancer by hormone and HER-2 receptors.
Brouckaert O, Pintens S, Van Belle V, Van Huffel S, Camerlynck E, Amant F, Leunen K, Smeets A, Berteloot P, Van Limbergen E, Decock J, Hendrickx W, Weltens C, Van den Bogaert W, Vanden Bempt I, Drijkoningen M, Paridaens R, Wildiers H, Vergote I, Christiaens MR, Neven P
Breast cancer research and treatment 2009 May;115(2):349-58
Breast cancer research and treatment 2009 May;115(2):349-58
Ductal lavage is an inefficient method of biomarker measurement in high-risk women.
Khan SA, Lankes HA, Patil DB, Bryk M, Hou N, Ivancic D, Nayar R, Masood S, Rademaker A
Cancer prevention research (Philadelphia, Pa.) 2009 Mar;2(3):265-73
Cancer prevention research (Philadelphia, Pa.) 2009 Mar;2(3):265-73
Normal breast tissue implanted into athymic nude mice identifies biomarkers of the effects of human pregnancy levels of estrogen.
Blance RN, Sims AH, Anderson E, Howell A, Clarke RB
Cancer prevention research (Philadelphia, Pa.) 2009 Mar;2(3):257-64
Cancer prevention research (Philadelphia, Pa.) 2009 Mar;2(3):257-64
Rabbit antibodies for hormone receptors and HER2 evaluation in breast cancer.
Rocha RM, Nunes CB, Sanches FS, Rocha GF, Oliveira FN, Reis-Filho JS, Lambros MB, Gobbi H
Revista da Associacao Medica Brasileira (1992) 2009 Mar-Apr;55(2):163-8
Revista da Associacao Medica Brasileira (1992) 2009 Mar-Apr;55(2):163-8
Rabbit antibodies for hormone receptors and HER2 evaluation in breast cancer.
Rocha RM, Nunes CB, Sanches FS, Rocha GF, Oliveira FN, Reis-Filho JS, Lambros MB, Gobbi H
Revista da Associacao Medica Brasileira (1992) 2009 Mar-Apr;55(2):163-8
Revista da Associacao Medica Brasileira (1992) 2009 Mar-Apr;55(2):163-8
Uterine carcinosarcoma metastatic to the lung as large-cell neuroendocrine carcinoma with synchronous sarcoid granulomatosis.
Froio E, D'Adda T, Fellegara G, Martella E, Caruana P, Pruneri G, Pesci A, Rindi G
Lung cancer (Amsterdam, Netherlands) 2009 Jun;64(3):371-7
Lung cancer (Amsterdam, Netherlands) 2009 Jun;64(3):371-7
Expression of ER, Ki-67 and cylinD1 in the pre-cancerous breast of Chinese patients.
Zhou CJ, Zhang QH, Zhang TG, Sun SZ, Li H, Wang Y, Liu ZY
Pathology oncology research : POR 2009 Jun;15(2):153-8
Pathology oncology research : POR 2009 Jun;15(2):153-8
Triple negative breast carcinoma is a prognostic factor in Taiwanese women.
Lin C, Chien SY, Chen LS, Kuo SJ, Chang TW, Chen DR
BMC cancer 2009 Jun 18;9:192
BMC cancer 2009 Jun 18;9:192
Tissue microarray validation: a methodologic study with special reference to lung cancer.
Karlsson C, Bodin L, Piehl-Aulin K, Karlsson MG
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009 Jul;18(7):2014-21
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009 Jul;18(7):2014-21
The potential biomarkers in predicting pathologic response of breast cancer to three different chemotherapy regimens: a case control study.
Wang L, Jiang Z, Sui M, Shen J, Xu C, Fan W
BMC cancer 2009 Jul 11;9:226
BMC cancer 2009 Jul 11;9:226
A limited panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary.
Köbel M, Kalloger SE, Carrick J, Huntsman D, Asad H, Oliva E, Ewanowich CA, Soslow RA, Gilks CB
The American journal of surgical pathology 2009 Jan;33(1):14-21
The American journal of surgical pathology 2009 Jan;33(1):14-21
Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive.
Van Calster B, Vanden Bempt I, Drijkoningen M, Pochet N, Cheng J, Van Huffel S, Hendrickx W, Decock J, Huang HJ, Leunen K, Amant F, Berteloot P, Paridaens R, Wildiers H, Van Limbergen E, Weltens C, Timmerman D, Van Gorp T, Smeets A, Van den Bogaert W, Vergote I, Christiaens MR, Neven P
Breast cancer research and treatment 2009 Jan;113(1):181-7
Breast cancer research and treatment 2009 Jan;113(1):181-7
Apolipoprotein D predicts adverse outcome in women >or=70 years with operable breast cancer.
Søiland H, Janssen EA, Kørner H, Varhaug JE, Skaland I, Gudlaugsson E, Baak JP, Søreide JA
Breast cancer research and treatment 2009 Feb;113(3):519-28
Breast cancer research and treatment 2009 Feb;113(3):519-28
Evaluation of new monoclonal antibodies in detection of estrogen receptor, progesterone receptor, and Her2 protein expression in breast carcinoma cell block sections using conventional microscopy and quantitative image analysis.
Hanley KZ, Siddiqui MT, Lawson D, Cohen C, Nassar A
Diagnostic cytopathology 2009 Apr;37(4):251-7
Diagnostic cytopathology 2009 Apr;37(4):251-7
Correlation of ultrasound findings with histology, tumor grade, and biological markers in breast cancer.
Kim SH, Seo BK, Lee J, Kim SJ, Cho KR, Lee KY, Je BK, Kim HY, Kim YS, Lee JH
Acta oncologica (Stockholm, Sweden) 2008;47(8):1531-8
Acta oncologica (Stockholm, Sweden) 2008;47(8):1531-8
Rabbit monoclonal antibodies show higher sensitivity than mouse monoclonals for estrogen and progesterone receptor evaluation in breast cancer by immunohistochemistry.
Rocha R, Nunes C, Rocha G, Oliveira F, Sanches F, Gobbi H
Pathology, research and practice 2008;204(9):655-62
Pathology, research and practice 2008;204(9):655-62
Apocrine carcinomas of the breast in Turkish women: hormone receptors, c-erbB-2 and p53 immunoexpression.
Kaya H, Bozkurt SU, Erbarut I, Djamgoz MB
Pathology, research and practice 2008;204(6):367-71
Pathology, research and practice 2008;204(6):367-71
The coexistence of invasive ductal carcinoma and malignant phyllodes tumor with liposarcomatous and chondrosarcomatous differentiation in the same breast in a post-osteosarcoma case.
Kefeli M, Yildiz L, Akpolat I, Balci P, Ozen N
Pathology, research and practice 2008;204(12):919-23
Pathology, research and practice 2008;204(12):919-23
ERalpha-status of disseminated tumour cells in bone marrow of primary breast cancer patients.
Fehm T, Krawczyk N, Solomayer EF, Becker-Pergola G, Dürr-Störzer S, Neubauer H, Seeger H, Staebler A, Wallwiener D, Becker S
Breast cancer research : BCR 2008;10(5):R76
Breast cancer research : BCR 2008;10(5):R76
Can clinically relevant prognostic subsets of breast cancer patients with four or more involved axillary lymph nodes be identified through immunohistochemical biomarkers? A tissue microarray feasibility study.
Crabb SJ, Bajdik CD, Leung S, Speers CH, Kennecke H, Huntsman DG, Gelmon KA
Breast cancer research : BCR 2008;10(1):R6
Breast cancer research : BCR 2008;10(1):R6
Expression of basal keratins and vimentin in breast cancers of young women correlates with adverse pathologic parameters.
Chen MH, Yip GW, Tse GM, Moriya T, Lui PC, Zin ML, Bay BH, Tan PH
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2008 Oct;21(10):1183-91
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2008 Oct;21(10):1183-91
In vivo measurement of tumor estradiol and vascular endothelial growth factor in breast cancer patients.
Garvin S, Dabrosin C
BMC cancer 2008 Mar 18;8:73
BMC cancer 2008 Mar 18;8:73
Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype.
Cheang MC, Voduc D, Bajdik C, Leung S, McKinney S, Chia SK, Perou CM, Nielsen TO
Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Mar 1;14(5):1368-76
Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Mar 1;14(5):1368-76
Down-regulation of claudin-2 in breast carcinomas is associated with advanced disease.
Kim TH, Huh JH, Lee S, Kang H, Kim GI, An HJ
Histopathology 2008 Jul;53(1):48-55
Histopathology 2008 Jul;53(1):48-55
Distribution and significance of caveolin 2 expression in normal breast and invasive breast cancer: an immunofluorescence and immunohistochemical analysis.
Savage K, Leung S, Todd SK, Brown LA, Jones RL, Robertson D, James M, Parry S, Rodrigues Pinilla SM, Huntsman D, Reis-Filho JS
Breast cancer research and treatment 2008 Jul;110(2):245-56
Breast cancer research and treatment 2008 Jul;110(2):245-56
Age interacts with the expression of steroid and HER-2 receptors in operable invasive breast cancer.
Neven P, Van Calster B, Van den Bempt I, Van Huffel S, Van Belle V, Hendrickx W, Decock J, Wildiers H, Paridaens R, Amant F, Leunen K, Berteloot P, Timmerman D, Van Limbergen E, Weltens C, Van den Bogaert W, Smeets A, Vergote I, Christiaens MR, Drijkoningen M
Breast cancer research and treatment 2008 Jul;110(1):153-9
Breast cancer research and treatment 2008 Jul;110(1):153-9
Parafibromin expression in breast cancer: a novel marker for prognostication?
Selvarajan S, Sii LH, Lee A, Yip G, Bay BH, Tan MH, Teh BT, Tan PH
Journal of clinical pathology 2008 Jan;61(1):64-7
Journal of clinical pathology 2008 Jan;61(1):64-7
Prostanoid receptor EP1 expression in breast cancer.
Thorat MA, Morimiya A, Mehrotra S, Konger R, Badve SS
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2008 Jan;21(1):15-21
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2008 Jan;21(1):15-21
Stromal mast cells in invasive breast cancer are a marker of favourable prognosis: a study of 4,444 cases.
Rajput AB, Turbin DA, Cheang MC, Voduc DK, Leung S, Gelmon KA, Gilks CB, Huntsman DG
Breast cancer research and treatment 2008 Jan;107(2):249-57
Breast cancer research and treatment 2008 Jan;107(2):249-57
Clinical validation of a customized multiple signature microarray for breast cancer.
Tan BK, Tan LK, Yu K, Tan PH, Lee M, Sii LH, Wong CY, Ho GH, Yeo AW, Chow PK, Koong HN, Yong WS, Lim DT, Ooi LL, Soo KC, Tan P
Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Jan 15;14(2):461-9
Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Jan 15;14(2):461-9
Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist?
De Maeyer L, Van Limbergen E, De Nys K, Moerman P, Pochet N, Hendrickx W, Wildiers H, Paridaens R, Smeets A, Christiaens MR, Vergote I, Leunen K, Amant F, Neven P
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008 Jan 10;26(2):335-6; author reply 336-8
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008 Jan 10;26(2):335-6; author reply 336-8
Both germ line and somatic genetics of the p53 pathway affect ovarian cancer incidence and survival.
Bartel F, Jung J, Böhnke A, Gradhand E, Zeng K, Thomssen C, Hauptmann S
Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Jan 1;14(1):89-96
Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Jan 1;14(1):89-96
Expression of aromatase and estrogen receptors in human adrenocortical tumors.
Barzon L, Masi G, Pacenti M, Trevisan M, Fallo F, Remo A, Martignoni G, Montanaro D, Pezzi V, Palù G
Virchows Archiv : an international journal of pathology 2008 Feb;452(2):181-91
Virchows Archiv : an international journal of pathology 2008 Feb;452(2):181-91
Amplified in breast cancer 1 expression in breast cancer.
Thorat MA, Turbin D, Morimiya A, Leung S, Zhang Q, Jeng MH, Huntsman DG, Nakshatri H, Badve S
Histopathology 2008 Dec;53(6):634-41
Histopathology 2008 Dec;53(6):634-41
Amplified in breast cancer 1 expression in breast cancer.
Thorat MA, Turbin D, Morimiya A, Leung S, Zhang Q, Jeng MH, Huntsman DG, Nakshatri H, Badve S
Histopathology 2008 Dec;53(6):634-41
Histopathology 2008 Dec;53(6):634-41
Prognostic relevance of androgen receptor detection in operable breast cancer.
Søiland H, Kørner H, Skaland I, Janssen EA, Gudlaugsson E, Varhaug JE, Baak JP, Søreide JA
Journal of surgical oncology 2008 Dec 1;98(7):551-8
Journal of surgical oncology 2008 Dec 1;98(7):551-8
Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 cases.
Turbin DA, Leung S, Cheang MC, Kennecke HA, Montgomery KD, McKinney S, Treaba DO, Boyd N, Goldstein LC, Badve S, Gown AM, van de Rijn M, Nielsen TO, Gilks CB, Huntsman DG
Breast cancer research and treatment 2008 Aug;110(3):417-26
Breast cancer research and treatment 2008 Aug;110(3):417-26
In early-stage breast cancer, the estrogen receptor interacts with correlation between human epidermal growth factor receptor 2 status and age at diagnosis, tumor grade, and lymph node involvement.
Neven P, Brouckaert O, Van Belle V, Vanden Bempt I, Hendrickx W, Cho H, Deraedt K, Van Calster B, Van Huffel S, Moerman P, Amant F, Leunen K, Smeets A, Wildiers H, Paridaens R, Vergote I, Christiaens MR
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008 Apr 1;26(10):1768-9; author reply 1769-71
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008 Apr 1;26(10):1768-9; author reply 1769-71
An oestrogen-dependent model of breast cancer created by transformation of normal human mammary epithelial cells.
Duss S, André S, Nicoulaz AL, Fiche M, Bonnefoi H, Brisken C, Iggo RD
Breast cancer research : BCR 2007;9(3):R38
Breast cancer research : BCR 2007;9(3):R38
Expression of c-kit proto-oncogene product in breast cancer tissues.
Eroğlu A, Sari A
Medical oncology (Northwood, London, England) 2007;24(2):169-74
Medical oncology (Northwood, London, England) 2007;24(2):169-74
Expression of c-kit proto-oncogene product in breast cancer tissues.
Eroğlu A, Sari A
Medical oncology (Northwood, London, England) 2007;24(2):169-74
Medical oncology (Northwood, London, England) 2007;24(2):169-74
Matrix metalloproteinase expression patterns in luminal A type breast carcinomas.
Decock J, Hendrickx W, Drijkoningen M, Wildiers H, Neven P, Smeets A, Paridaens R
Disease markers 2007;23(3):189-96
Disease markers 2007;23(3):189-96
Matrix metalloproteinase expression patterns in luminal A type breast carcinomas.
Decock J, Hendrickx W, Drijkoningen M, Wildiers H, Neven P, Smeets A, Paridaens R
Disease markers 2007;23(3):189-96
Disease markers 2007;23(3):189-96
Primary neuroendocrine carcinoma of the breast: a case report.
Yaren A, Kelten C, Akbulut M, Teke Z, Duzcan E, Erdem E
Tumori 2007 Sep-Oct;93(5):496-8
Tumori 2007 Sep-Oct;93(5):496-8
Primary neuroendocrine carcinoma of the breast: a case report.
Yaren A, Kelten C, Akbulut M, Teke Z, Duzcan E, Erdem E
Tumori 2007 Sep-Oct;93(5):496-8
Tumori 2007 Sep-Oct;93(5):496-8
Estrogen insensitivity in a model of estrogen receptor positive breast cancer lymph node metastasis.
Harrell JC, Dye WW, Harvell DM, Pinto M, Jedlicka P, Sartorius CA, Horwitz KB
Cancer research 2007 Nov 1;67(21):10582-91
Cancer research 2007 Nov 1;67(21):10582-91
Testosterone increases blood flow and expression of androgen and estrogen receptors in the rat vagina.
Traish AM, Kim SW, Stankovic M, Goldstein I, Kim NN
The journal of sexual medicine 2007 May;4(3):609-619
The journal of sexual medicine 2007 May;4(3):609-619
P27 V109G Polymorphism is associated with lymph node metastases but not with increased risk of breast cancer.
Naidu R, Har YC, Taib NA
Journal of experimental & clinical cancer research : CR 2007 Mar;26(1):133-40
Journal of experimental & clinical cancer research : CR 2007 Mar;26(1):133-40
Grading invasive ductal carcinoma of the breast: advantages of using automated proliferation index instead of mitotic count.
Tawfik O, Kimler BF, Davis M, Stasik C, Lai SM, Mayo MS, Fan F, Donahue JK, Damjanov I, Thomas P, Connor C, Jewell WR, Smith H, Fabian CJ
Virchows Archiv : an international journal of pathology 2007 Jun;450(6):627-36
Virchows Archiv : an international journal of pathology 2007 Jun;450(6):627-36
Transitional cell carcinoma of the endometrium associated with benign ovarian brenner tumor: a case report with immunohistochemistry molecular analysis and a review of the literature.
Giordano G, D'Adda T, Gnetti L, Merisio C, Raboni S
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2007 Jul;26(3):298-304
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2007 Jul;26(3):298-304
The contribution of bifunctional SkipDewax pretreatment solution, rabbit monoclonal antibodies, and polymer detection systems in immunohistochemistry.
Wong SC, Chan JK, Lo ES, Chan AK, Wong MC, Chan CM, Lam MY, Chan AT
Archives of pathology & laboratory medicine 2007 Jul;131(7):1047-55
Archives of pathology & laboratory medicine 2007 Jul;131(7):1047-55
Characterization of a preclinical model of simultaneous breast and ovarian cancer progression.
Ting AY, Kimler BF, Fabian CJ, Petroff BK
Carcinogenesis 2007 Jan;28(1):130-5
Carcinogenesis 2007 Jan;28(1):130-5
Prognostic factors in Hungarian breast cancer patients.
Nádasi E, Anga B, Sándor J, Megyesi J, Kelemen D, Mottolese M, Natali PG, Hegedus G, Arany I, Ember I
Anticancer research 2007 Jan-Feb;27(1A):279-82
Anticancer research 2007 Jan-Feb;27(1A):279-82
Anaplastic thyroid carcinoma: expression profile of targets for therapy offers new insights for disease treatment.
Wiseman SM, Masoudi H, Niblock P, Turbin D, Rajput A, Hay J, Bugis S, Filipenko D, Huntsman D, Gilks B
Annals of surgical oncology 2007 Feb;14(2):719-29
Annals of surgical oncology 2007 Feb;14(2):719-29
Mammary fibroadenoma in a lamb.
Gulbahar MY, Guvenc T, Yarim M, Kabak YB, Sozgen Y
Journal of veterinary science 2007 Dec;8(4):423-5
Journal of veterinary science 2007 Dec;8(4):423-5
Mammary fibroadenoma in a lamb.
Gulbahar MY, Guvenc T, Yarim M, Kabak YB, Sozgen Y
Journal of veterinary science 2007 Dec;8(4):423-5
Journal of veterinary science 2007 Dec;8(4):423-5
A novel dual-target steroid sulfatase inhibitor and antiestrogen: SR 16157, a promising agent for the therapy of breast cancer.
Rasmussen LM, Zaveri NT, Stenvang J, Peters RH, Lykkesfeldt AE
Breast cancer research and treatment 2007 Dec;106(2):191-203
Breast cancer research and treatment 2007 Dec;106(2):191-203
FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
Badve S, Turbin D, Thorat MA, Morimiya A, Nielsen TO, Perou CM, Dunn S, Huntsman DG, Nakshatri H
Clinical cancer research : an official journal of the American Association for Cancer Research 2007 Aug 1;13(15 Pt 1):4415-21
Clinical cancer research : an official journal of the American Association for Cancer Research 2007 Aug 1;13(15 Pt 1):4415-21
Villoglandular adenocarcinoma of the cervix: two new cases with morphological and molecular study.
Giordano G, D'Adda T, Gnetti L, Merisio C, Gabrielli M, Melpignano M
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2007 Apr;26(2):199-204
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2007 Apr;26(2):199-204
The significance of c-erbB-2 overexpression and p53 expression in patients with axillary lymph node--negative breast cancer: a tissue microarray study.
Ko SS, Na YS, Yoon CS, Park JY, Kim HS, Hur MH, Lee HK, Chun YK, Kang SS, Park BW, Lee JH
International journal of surgical pathology 2007 Apr;15(2):98-109
International journal of surgical pathology 2007 Apr;15(2):98-109
Para-testicular cellular angiofibroma: a rare tumour in a male renal transplant patient.
Sabah M, Mohan P, Kay E
Virchows Archiv : an international journal of pathology 2006 Oct;449(4):489-92
Virchows Archiv : an international journal of pathology 2006 Oct;449(4):489-92
Ovarian metastases of intestinal-type gastric carcinoma: A clinicopathologic study of 4 cases with contrasting features to those of the Krukenberg tumor.
Lerwill MF, Young RH
The American journal of surgical pathology 2006 Nov;30(11):1382-8
The American journal of surgical pathology 2006 Nov;30(11):1382-8
Hypercalcemia induced by ovarian clear cell carcinoma producing all transcriptional variants of parathyroid hormone-related peptide gene during pregnancy.
Hwang CS, Park SY, Yu SH, Park JY, Park CT, Han KO
Gynecologic oncology 2006 Nov;103(2):740-4
Gynecologic oncology 2006 Nov;103(2):740-4
Effect of c-neu/ ErbB2 expression levels on estrogen receptor alpha-dependent proliferation in mammary epithelial cells: implications for breast cancer biology.
Shyamala G, Chou YC, Cardiff RD, Vargis E
Cancer research 2006 Nov 1;66(21):10391-8
Cancer research 2006 Nov 1;66(21):10391-8
Antagonist-induced, activation function-2-independent estrogen receptor alpha phosphorylation.
Lipfert L, Fisher JE, Wei N, Scafonas A, Su Q, Yudkovitz J, Chen F, Warrier S, Birzin ET, Kim S, Chen HY, Tan Q, Schmidt A, Dininno F, Rohrer SP, Hammond ML, Rodan GA, Freedman LP, Reszka AA
Molecular endocrinology (Baltimore, Md.) 2006 Mar;20(3):516-33
Molecular endocrinology (Baltimore, Md.) 2006 Mar;20(3):516-33
Conditionally activated E7 proteins of high-risk and low-risk human papillomaviruses induce S phase in postmitotic, differentiated human keratinocytes.
Banerjee NS, Genovese NJ, Noya F, Chien WM, Broker TR, Chow LT
Journal of virology 2006 Jul;80(13):6517-24
Journal of virology 2006 Jul;80(13):6517-24
Preoperative and intraoperative diagnosis of low-grade adenosquamous carcinoma of the breast: potential diagnostic pitfalls.
Ho BC, Tan HW, Lee VK, Tan PH
Histopathology 2006 Dec;49(6):603-11
Histopathology 2006 Dec;49(6):603-11
Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survival.
Cheang MC, Treaba DO, Speers CH, Olivotto IA, Bajdik CD, Chia SK, Goldstein LC, Gelmon KA, Huntsman D, Gilks CB, Nielsen TO, Gown AM
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006 Dec 20;24(36):5637-44
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006 Dec 20;24(36):5637-44
Estradiol increases VEGF in human breast studied by whole-tissue culture.
Garvin S, Nilsson UW, Huss FR, Kratz G, Dabrosin C
Cell and tissue research 2006 Aug;325(2):245-51
Cell and tissue research 2006 Aug;325(2):245-51
Insulin-like growth factor binding protein 2 is a marker for antiestrogen resistant human breast cancer cell lines but is not a major growth regulator.
Juncker-Jensen A, Lykkesfeldt AE, Worm J, Ralfkiaer U, Espelund U, Jepsen JS
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2006 Aug;16(4):224-39
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2006 Aug;16(4):224-39
Synchronous endometrial and cervical tumors in a 26-year-old nullipara: diagnostic modalities updated.
Hascalik S, Celik O, Erdem G, Usta U, Alkan A, Karakas HM, Mizrak B
Gynecologic and obstetric investigation 2005;60(3):171-6
Gynecologic and obstetric investigation 2005;60(3):171-6
p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas.
Matos I, Dufloth R, Alvarenga M, Zeferino LC, Schmitt F
Virchows Archiv : an international journal of pathology 2005 Oct;447(4):688-94
Virchows Archiv : an international journal of pathology 2005 Oct;447(4):688-94
Mucinous cystic tumor of the pancreas with ovarian-like mesenchymal stroma in a male patient.
Goh BK, Tan YM, Kumarasinghe MP, Ooi LL
Digestive diseases and sciences 2005 Nov;50(11):2170-7
Digestive diseases and sciences 2005 Nov;50(11):2170-7
Endocrine biomarkers in ductal lavage samples from women at high risk for breast cancer.
Bhandare D, Nayar R, Bryk M, Hou N, Cohn R, Golewale N, Parker NP, Chatterton RT, Rademaker A, Khan SA
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005 Nov;14(11 Pt 1):2620-7
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005 Nov;14(11 Pt 1):2620-7
Primary squamous cell carcinoma of the endometrium: a case report with immunohistochemical and molecular study.
Giordano G, D'Adda T, Merisio C, Gnetti L
Gynecologic oncology 2005 Mar;96(3):876-9
Gynecologic oncology 2005 Mar;96(3):876-9
The activation function-1 domain of estrogen receptor alpha in uterine stromal cells is required for mouse but not human uterine epithelial response to estrogen.
Kurita T, Medina R, Schabel AB, Young P, Gama P, Parekh TV, Brody J, Cunha GR, Osteen KG, Bruner-Tran KL, Gold LI
Differentiation; research in biological diversity 2005 Jul;73(6):313-22
Differentiation; research in biological diversity 2005 Jul;73(6):313-22
Endogenous aromatization of testosterone results in growth stimulation of the human MCF-7 breast cancer cell line.
Sonne-Hansen K, Lykkesfeldt AE
The Journal of steroid biochemistry and molecular biology 2005 Jan;93(1):25-34
The Journal of steroid biochemistry and molecular biology 2005 Jan;93(1):25-34
A membrane estrogen receptor mediates intracellular calcium release in astrocytes.
Chaban VV, Lakhter AJ, Micevych P
Endocrinology 2004 Aug;145(8):3788-95
Endocrinology 2004 Aug;145(8):3788-95
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot was performed using Estrogen Receptor alpha Monoclonal Antibody (Product # MA5-139540) and a 66kDa band corresponding to Estrogen Receptor alpha was observed across all the cell lines tested. Whole cell extracts (30 µg lysate) of T-47D (Lane 1), MCF-7 (Lane 2), SK-BR-3 (Lane 3), HepG2 (Lane 4) were electrophoresed using NuPAGE™ 4-12% Bis-Tris Protein Gel (Product # NP0321BOX). Resolved proteins were then transferred onto a Nitrocellulose membrane (Product # IB23001) by iBlot® 2 Dry Blotting System (Product # IB21001). The blot was probed with the primary antibody (1:1000 dilution) and detected by chemiluminescence with Goat anti-Rabbit IgG (H+L), Superclonal™ Recombinant Secondary Antibody, HRP (Product # A27036, 1:4000 dilution) using the iBright FL 1000 (Product # A32752). Chemiluminescent detection was performed using Novex® ECL Chemiluminescent Substrate Reagent Kit (Product # WP20005).
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunofluorescence analysis of Estrogen Receptor alpha was performed using 70% confluent log phase T-47D cells. The cells were fixed with 4% paraformaldehyde for 10 minutes, permeabilized with 0.1% Triton™ X-100 for 15 minutes, and blocked with 2% BSA for 45 minutes at room temperature. The cells were labeled with beta Estrogen Receptor alpha Monoclonal Antibody (Product # MA1-39540) at 1:200 dilution in 0.1% BSA, incubated at 4 degree celsius overnight and then labeled with Goat anti-Mouse IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor Plus 488 (Product # A32723), (1:2000 dilution), for 45 minutes at room temperature (Panel a: Green). Nuclei (Panel b: Blue) were stained with ProLong™ Diamond Antifade Mountant with DAPI (Product # P36962). F-actin (Panel c: Red) was stained with Rhodamine Phalloidin (Product # R415, 1:300). Panel d represents the merged image showing nuclear localization. Panel e represents merged image for SK-BR-3 cells showing no staining for Estrogen Receptor alpha. Panel f represents control cells with no primary antibody to assess background. The images were captured at 60X magnification.
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunohistochemical analysis of Estrogen Receptor alpha using a monoclonal antibody (Product # MA1-39540).
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Chromatin Immunoprecipitation (ChIP) assay of endogenous Estrogen Receptor alpha protein using ESR alpha Antibody: ChIP was performed using Anti-Estrogen Receptor alpha Monoclonal Antibody (SP1) (Product # MA1-39540, 5 ul) on sheared chromatin from MCF7 cells treated with beta estradiol (10 nm for 45 mins) using the MAGnify ChIP System kit (Product # 49-2024). Chromatin from untreated MCF7 cells were prepared the same way. Normal Rabbit IgG was used as a negative IP control. The purified DNA was analyzed by qPCR using primers binding to XBP1, GREB1 and RARA (Active) and GAPDH (+4.5kb downstream of promoter) and SAT2 satellite repeats (Inactive). Data is presented as fold enrichment of the antibody signal versus the negative control IgG using the comparative CT method.
